{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:43:12Z","timestamp":1793227392782,"version":"4.5.0"},"reference-count":215,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Trace Elem Res"],"DOI":"10.1007\/s12011-026-05026-4","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T14:20:44Z","timestamp":1770992444000},"page":"5212-5235","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Selenium-Containing Compounds in Breast Cancer Therapy"],"prefix":"10.1007","volume":"204","author":[{"given":"Elena G.","family":"Varlamova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,13]]},"reference":[{"issue":"2","key":"5026_CR1","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1158\/2159-8290.CD-18-1177","volume":"9","author":"AC Garrido-Castro","year":"2019","unstructured":"Garrido-Castro AC, Lin NU, Polyak K (2019) Insights into molecular classifications of Triple-Negative breast cancer: improving patient selection for treatment. Cancer Discov 9(2):176\u2013198. https:\/\/doi.org\/10.1158\/2159-8290.CD-18-1177","journal-title":"Cancer Discov"},{"issue":"19","key":"5026_CR2","doi-asserted-by":"publisher","first-page":"10869","DOI":"10.1073\/pnas.191367098","volume":"98","author":"T S\u00f8rlie","year":"2001","unstructured":"S\u00f8rlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, L\u00f8nning PE, B\u00f8rresen-Dale AL (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 98(19):10869\u201310874. https:\/\/doi.org\/10.1073\/pnas.191367098","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"14","key":"5026_CR3","doi-asserted-by":"publisher","first-page":"8418","DOI":"10.1073\/pnas.0932692100","volume":"100","author":"T Sorlie","year":"2003","unstructured":"Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, Deng S, Johnsen H, Pesich R, Geisler S, Demeter J, Perou CM, L\u00f8nning PE, Brown PO, B\u00f8rresen-Dale AL, Botstein D (2003) Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A 100(14):8418\u20138423. https:\/\/doi.org\/10.1073\/pnas.0932692100","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"5026_CR4","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1002\/cncr.23243","volume":"112","author":"M Brown","year":"2008","unstructured":"Brown M, Tsodikov A, Bauer KR, Parise CA, Caggiano V (2008) The role of human epidermal growth factor receptor 2 in the survival of women with Estrogen and progesterone receptor-negative, invasive breast cancer: the California cancer Registry, 1999\u20132004. Cancer 112(4):737\u2013747. https:\/\/doi.org\/10.1002\/cncr.23243","journal-title":"Cancer"},{"issue":"1","key":"5026_CR5","doi-asserted-by":"publisher","first-page":"46","DOI":"10.5858\/arpa.2022-0070-RA","volume":"147","author":"X Zhang","year":"2023","unstructured":"Zhang X (2023) Molecular classification of breast cancer: relevance and challenges. Arch Pathol Lab Med 147(1):46\u201351. https:\/\/doi.org\/10.5858\/arpa.2022-0070-RA","journal-title":"Arch Pathol Lab Med"},{"key":"5026_CR6","doi-asserted-by":"publisher","first-page":"104351","DOI":"10.1016\/j.critrevonc.2024.104351","volume":"197","author":"MM Khan","year":"2024","unstructured":"Khan MM, Yalamarty SSK, Rajmalani BA, Filipczak N, Torchilin VP (2024) Recent strategies to overcome breast cancer resistance. Crit Rev Oncol Hematol 197:104351. https:\/\/doi.org\/10.1016\/j.critrevonc.2024.104351","journal-title":"Crit Rev Oncol Hematol"},{"issue":"5","key":"5026_CR7","doi-asserted-by":"publisher","first-page":"R68","DOI":"10.1186\/bcr2635","volume":"12","author":"A Prat","year":"2010","unstructured":"Prat A, Parker JS, Karginova O, Fan C, Livasy C, Herschkowitz JI, He X, Perou CM (2010) Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Res 12(5):R68. https:\/\/doi.org\/10.1186\/bcr2635","journal-title":"Breast Cancer Res"},{"issue":"3","key":"5026_CR8","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1001\/jama.2018.19323","volume":"321","author":"AG Waks","year":"2019","unstructured":"Waks AG, Winer EP (2019) Breast cancer treatment: A review. JAMA 321(3):288\u2013300. https:\/\/doi.org\/10.1001\/jama.2018.19323","journal-title":"JAMA"},{"issue":"1","key":"5026_CR9","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41392-024-02108-4","volume":"10","author":"X Xiong","year":"2025","unstructured":"Xiong X, Zheng LW, Ding Y, Chen YF, Cai YW, Wang LP, Huang L, Liu CC, Shao ZM, Yu KD (2025) Breast cancer: pathogenesis and treatments. Signal Transduct Target Ther 10(1):49. https:\/\/doi.org\/10.1038\/s41392-024-02108-4","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"5026_CR10","doi-asserted-by":"publisher","first-page":"155932581879633","DOI":"10.1177\/1559325818796331","volume":"16","author":"A Vaiserman","year":"2018","unstructured":"Vaiserman A, Koliada A, Zabuga O, Socol Y (2018) Health impacts of Low-Dose ionizing radiation: current scientific debates and regulatory issues. Dose Response 16(3):1559325818796331. https:\/\/doi.org\/10.1177\/1559325818796331","journal-title":"Dose Response"},{"issue":"10","key":"5026_CR11","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1002\/ijc.30235","volume":"139","author":"G Yang","year":"2016","unstructured":"Yang G, Li W, Jiang H, Liang X, Zhao Y, Yu D, Zhou L, Wang G, Tian H, Han F, Cai L, Cui J (2016) Low-dose radiation May be a novel approach to enhance the effectiveness of cancer therapeutics. Int J Cancer 139(10):2157\u20132168. https:\/\/doi.org\/10.1002\/ijc.30235","journal-title":"Int J Cancer"},{"issue":"1","key":"5026_CR12","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1007\/s12011-022-03146-1","volume":"201","author":"OAR Abozaid","year":"2023","unstructured":"Abozaid OAR, Rashed LA, El-Sonbaty SM, Abu-Elftouh AI, Ahmed ESA (2023) Mesenchymal stem cells and selenium nanoparticles synergize with low dose of gamma radiation to suppress mammary gland carcinogenesis via regulation of tumor microenvironment. Biol Trace Elem Res 201(1):338\u2013352. https:\/\/doi.org\/10.1007\/s12011-022-03146-1","journal-title":"Biol Trace Elem Res"},{"issue":"3","key":"5026_CR13","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1097\/HP.0000000000000450","volume":"110","author":"EI Azzam","year":"2016","unstructured":"Azzam EI, Colangelo NW, Domogauer JD, Sharma N, de Toledo SM (2016) Is ionizing radiation harmful at any exposure? An echo that continues to vibrate. Health Phys 110(3):249\u2013251. https:\/\/doi.org\/10.1097\/HP.0000000000000450","journal-title":"Health Phys"},{"issue":"1","key":"5026_CR14","doi-asserted-by":"publisher","first-page":"39","DOI":"10.2203\/dose-response.06-108.Liu","volume":"5","author":"SZ Liu","year":"2006","unstructured":"Liu SZ (2006) Cancer control related to stimulation of immunity by low-dose radiation. Dose Response 5(1):39\u201347. https:\/\/doi.org\/10.2203\/dose-response.06-108.Liu","journal-title":"Dose Response"},{"issue":"1","key":"5026_CR15","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3164\/jcbn.D-11-00021","volume":"50","author":"K Anzai","year":"2012","unstructured":"Anzai K, Ban N, Ozawa T, Tokonami S (2012) Fukushima Daiichi nuclear power plant accident: facts, environmental contamination, possible biological effects, and countermeasures. J Clin Biochem Nutr 50(1):2\u20138. https:\/\/doi.org\/10.3164\/jcbn.D-11-00021","journal-title":"J Clin Biochem Nutr"},{"issue":"5","key":"5026_CR16","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1038\/cdd.2014.24","volume":"21","author":"R Lall","year":"2014","unstructured":"Lall R, Ganapathy S, Yang M, Xiao S, Xu T, Su H, Shadfan M, Asara JM, Ha CS, Ben-Sahra I, Manning BD, Little JB, Yuan ZM (2014) Low-dose radiation exposure induces a HIF-1-mediated adaptive and protective metabolic response. Cell Death Differ 21(5):836\u2013844. https:\/\/doi.org\/10.1038\/cdd.2014.24","journal-title":"Cell Death Differ"},{"issue":"8","key":"5026_CR17","doi-asserted-by":"publisher","first-page":"101118","DOI":"10.1016\/j.tranon.2021.101118","volume":"14","author":"Z Chen","year":"2021","unstructured":"Chen Z, Wu Z, Muluh TA, Fu S, Wu J (2021) Effect of low-dose total-body radiotherapy on immune microenvironment. Transl Oncol 14(8):101118. https:\/\/doi.org\/10.1016\/j.tranon.2021.101118","journal-title":"Transl Oncol"},{"issue":"6","key":"5026_CR18","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.stem.2012.05.015","volume":"10","author":"A Keating","year":"2012","unstructured":"Keating A (2012) Mesenchymal stromal cells: new directions. Cell Stem Cell 10(6):709\u2013716. https:\/\/doi.org\/10.1016\/j.stem.2012.05.015","journal-title":"Cell Stem Cell"},{"issue":"7\u20138","key":"5026_CR19","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1080\/1061186X.2020.1775842","volume":"28","author":"R Heidari","year":"2020","unstructured":"Heidari R, Gholamian Dehkordi N, Mohseni R, Safaei M (2020) Engineering mesenchymal stem cells: a novel therapeutic approach in breast cancer. J Drug Target 28(7\u20138):732\u2013741 https:\/\/doi.org\/10.1080\/1061186X.2020.1775842","journal-title":"J Drug Target 2020 Aug-Sep"},{"issue":"1","key":"5026_CR20","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s12935-021-01836-9","volume":"21","author":"S Aravindhan","year":"2021","unstructured":"Aravindhan S, Ejam SS, Lafta MH, Markov A, Yumashev AV, Ahmadi M (2021) Mesenchymal stem cells and cancer therapy: insights into targeting the tumour vasculature. Cancer Cell Int 21(1):158. https:\/\/doi.org\/10.1186\/s12935-021-01836-9","journal-title":"Cancer Cell Int"},{"issue":"10","key":"5026_CR21","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1038\/s41419-018-0949-3","volume":"9","author":"N He","year":"2018","unstructured":"He N, Kong Y, Lei X, Liu Y, Wang J, Xu C, Wang Y, Du L, Ji K, Wang Q, Li Z, Liu Q (2018) MSCs inhibit tumor progression and enhance radiosensitivity of breast cancer cells by down-regulating Stat3 signaling pathway. Cell Death Dis 9(10):1026. https:\/\/doi.org\/10.1038\/s41419-018-0949-3","journal-title":"Cell Death Dis"},{"issue":"1","key":"5026_CR22","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s13045-021-01208-w","volume":"14","author":"T Lan","year":"2021","unstructured":"Lan T, Luo M, Wei X (2021) Mesenchymal stem\/stromal cells in cancer therapy. J Hematol Oncol 14(1):195. https:\/\/doi.org\/10.1186\/s13045-021-01208-w","journal-title":"J Hematol Oncol"},{"issue":"23","key":"5026_CR23","doi-asserted-by":"publisher","first-page":"16607","DOI":"10.3390\/ijms242316607","volume":"24","author":"T Yang","year":"2023","unstructured":"Yang T, Li W, Huang T, Zhou J (2023) Genetic testing enhances the precision diagnosis and treatment of breast cancer. Int J Mol Sci 24(23):16607. https:\/\/doi.org\/10.3390\/ijms242316607","journal-title":"Int J Mol Sci"},{"issue":"2","key":"5026_CR24","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.mcna.2022.10.007","volume":"107","author":"E Michaels","year":"2023","unstructured":"Michaels E, Worthington RO, Rusiecki J, Breast, Cancer (2023) Risk Assessment, Screening, and primary prevention. Med Clin North Am 107(2):271\u2013284. https:\/\/doi.org\/10.1016\/j.mcna.2022.10.007","journal-title":"Med Clin North Am"},{"issue":"55","key":"5026_CR25","doi-asserted-by":"publisher","first-page":"552","DOI":"10.6004\/jnccn.2019.5006","volume":"17","author":"ML Telli","year":"2019","unstructured":"Telli ML, Gradishar WJ, Ward JH (2019) NCCN guidelines updates: breast cancer. J Natl Compr Canc Netw 17(55):552\u2013555. https:\/\/doi.org\/10.6004\/jnccn.2019.5006","journal-title":"J Natl Compr Canc Netw"},{"key":"5026_CR26","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.breast.2016.06.018","volume":"29","author":"JL Dillon","year":"2016","unstructured":"Dillon JL, Mockus SM, Ananda G, Spotlow V, Wells WA, Tsongalis GJ, Marotti JD (2016) Somatic gene mutation analysis of triple negative breast cancers. Breast 29:202\u2013207. https:\/\/doi.org\/10.1016\/j.breast.2016.06.018","journal-title":"Breast"},{"issue":"5","key":"5026_CR27","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/modpathol.2016.39","volume":"29","author":"PS Weisman","year":"2016","unstructured":"Weisman PS, Ng CK, Brogi E, Eisenberg RE, Won HH, Piscuoglio S, De Filippo MR, Ioris R, Akram M, Norton L, Weigelt B, Berger MF, Reis-Filho JS, Wen HY (2016) Genetic alterations of triple negative breast cancer by targeted next-generation sequencing and correlation with tumor morphology. Mod Pathol 29(5):476\u2013488. https:\/\/doi.org\/10.1038\/modpathol.2016.39","journal-title":"Mod Pathol"},{"key":"5026_CR28","doi-asserted-by":"publisher","first-page":"797505","DOI":"10.3389\/fonc.2021.797505","volume":"11","author":"A Andrikopoulou","year":"2022","unstructured":"Andrikopoulou A, Chatzinikolaou S, Kyriopoulos I, Bletsa G, Kaparelou M, Liontos M, Dimopoulos MA, Zagouri F (2022) The mutational landscape of Early-Onset breast cancer: A Next-Generation sequencing analysis. Front Oncol 11:797505. https:\/\/doi.org\/10.3389\/fonc.2021.797505","journal-title":"Front Oncol"},{"issue":"41","key":"5026_CR29","doi-asserted-by":"publisher","first-page":"e2308639","DOI":"10.1002\/smll.202308639","volume":"20","author":"R Wang","year":"2024","unstructured":"Wang R, Kumar P, Reda M, Wallstrum AG, Crumrine NA, Ngamcherdtrakul W, Yantasee W (2024) Nanotechnology applications in breast cancer immunotherapy. Small 20(41):e2308639. https:\/\/doi.org\/10.1002\/smll.202308639","journal-title":"Small"},{"key":"5026_CR30","doi-asserted-by":"publisher","first-page":"1149554","DOI":"10.3389\/fphar.2023.1149554","volume":"14","author":"P Kumar","year":"2023","unstructured":"Kumar P, Mangla B, Javed S, Ahsan W, Musyuni P, Sivadasan D, Alqahtani SS, Aggarwal G (2023) A review of nanomaterials from synthetic and natural molecules for prospective breast cancer nanotherapy. Front Pharmacol 14:1149554. https:\/\/doi.org\/10.3389\/fphar.2023.1149554","journal-title":"Front Pharmacol"},{"issue":"2","key":"5026_CR31","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1021\/ab500084g","volume":"1","author":"A Ediriwickrema","year":"2015","unstructured":"Ediriwickrema A, Saltzman WM (2015) Nanotherapy for cancer: targeting and multifunctionality in the future of cancer therapies. ACS Biomater Sci Eng 1(2):64\u201378. https:\/\/doi.org\/10.1021\/ab500084g","journal-title":"ACS Biomater Sci Eng"},{"issue":"2","key":"5026_CR32","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.sjbs.2013.11.001","volume":"21","author":"KK Alharbi","year":"2014","unstructured":"Alharbi KK, Al-Sheikh YA (2014) Role and implications of nanodiagnostics in the changing trends of clinical diagnosis. Saudi J Biol Sci 21(2):109\u2013117. https:\/\/doi.org\/10.1016\/j.sjbs.2013.11.001","journal-title":"Saudi J Biol Sci"},{"key":"5026_CR33","doi-asserted-by":"publisher","first-page":"4619","DOI":"10.2147\/IJN.S379526","volume":"17","author":"Y Lv","year":"2022","unstructured":"Lv Y, Kan J, Luo M, Yang C, Luo X, Lin X, Li H, Li X, Li Y, Yang C, Liu Y, Li X (2022) Multifunctional nanosnowflakes for T1-T2 Double-Contrast enhanced MRI and PAI guided oxygen Self-Supplementing effective Anti-Tumor therapy. Int J Nanomed 17:4619\u20134638. https:\/\/doi.org\/10.2147\/IJN.S379526","journal-title":"Int J Nanomed"},{"issue":"1","key":"5026_CR34","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1134\/S1607672918030018","volume":"480","author":"YP Kuznetsova","year":"2018","unstructured":"Kuznetsova YP, Goltyaev MV, Gorbacheva OS, Novoselov SV, Varlamova EG, Fesenko EE (2018) Influence of sodium selenite on the mRNA expression of the mammalian Selenocysteine-Containing protein genes in testicle and prostate cancer cells. Dokl Biochem Biophys 480(1):131\u2013134. https:\/\/doi.org\/10.1134\/S1607672918030018","journal-title":"Dokl Biochem Biophys"},{"key":"5026_CR35","doi-asserted-by":"publisher","unstructured":"Varlamova EG, Goltyaev MV, Kuznetsova JP (2018) [Effect of sodium selenite on gene expression of SELF, SELW, and TGR selenoproteins in adenocarcinoma cells of the human Prostate]. Mol biol (Mosk). 52(3):519\u2013526 Russian https:\/\/doi.org\/10.7868\/S0026898418030151","DOI":"10.7868\/S0026898418030151"},{"issue":"1","key":"5026_CR36","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1134\/S1607672919050065","volume":"488","author":"EG Varlamova","year":"2019","unstructured":"Varlamova EG, Goltyaev MV, Fesenko EE (2019) Protein partners of Selenoprotein SELM and the role of selenium compounds in regulation of its expression in human cancer cells. Dokl Biochem Biophys 488(1):300\u2013303. https:\/\/doi.org\/10.1134\/S1607672919050065","journal-title":"Dokl Biochem Biophys"},{"issue":"1","key":"5026_CR37","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1134\/S160767292001007X","volume":"490","author":"MV Goltyaev","year":"2020","unstructured":"Goltyaev MV, Varlamova EG, Novoselov SV, Fesenko EE (2020) Activation of signal pathways of apoptosis under conditions of prolonged ER-Stress caused by exposure of mouse testicular teratoma cells to Selenium-Containing compounds. Dokl Biochem Biophys 490(1):9\u201311. https:\/\/doi.org\/10.1134\/S160767292001007X","journal-title":"Dokl Biochem Biophys"},{"issue":"4","key":"5026_CR38","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.3390\/ijms23042360","volume":"23","author":"VN Mal\u2019tseva","year":"2022","unstructured":"Mal\u2019tseva VN, Goltyaev MV, Turovsky EA, Varlamova EG (2022) Immunomodulatory and Anti-Inflammatory properties of Selenium-Containing agents: their role in the regulation of defense mechanisms against COVID-19. Int J Mol Sci 23(4):2360. https:\/\/doi.org\/10.3390\/ijms23042360","journal-title":"Int J Mol Sci"},{"key":"5026_CR39","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.jtemb.2016.05.005","volume":"37","author":"C Pfister","year":"2016","unstructured":"Pfister C, Dawzcynski H, Schingale FJ (2016) Sodium selenite and cancer related lymphedema: biological and Pharmacological effects. J Trace Elem Med Biol 37:111\u2013116. https:\/\/doi.org\/10.1016\/j.jtemb.2016.05.005","journal-title":"J Trace Elem Med Biol"},{"key":"5026_CR40","doi-asserted-by":"publisher","first-page":"6356583","DOI":"10.1155\/2022\/6356583","volume":"2022","author":"H Jiang","year":"2022","unstructured":"Jiang H, Hu L, Wu Q, Zhang B, Sun J, Li X (2022) Sodium selenite regulates the proliferation and apoptosis of gastric cancer cells by suppressing the expression of LncRNA HOXB-AS1. Evid Based Complement Alternat Med 2022:6356583. https:\/\/doi.org\/10.1155\/2022\/6356583","journal-title":"Evid Based Complement Alternat Med"},{"key":"5026_CR41","doi-asserted-by":"publisher","first-page":"123109","DOI":"10.1016\/j.lfs.2024.123109","volume":"357","author":"Q Zeng","year":"2024","unstructured":"Zeng Q, Lv C, Qi L, Wang Y, Hao S, Li G, Sun H, Du L, Li J, Wang C, Zhang Y, Wang X, Ma R, Wang T, Li Q (2024) Sodium selenite inhibits cervical cancer progression via ROS-mediated suppression of glucose metabolic reprogramming. Life Sci 357:123109. https:\/\/doi.org\/10.1016\/j.lfs.2024.123109","journal-title":"Life Sci"},{"key":"5026_CR42","doi-asserted-by":"publisher","first-page":"2486783","DOI":"10.1155\/2019\/2486783","volume":"2019","author":"B Wu","year":"2019","unstructured":"Wu B, Ge J, Zhang Z, Huang C, Li X, Tan Z, Fang X, Sun J (2019) Combination of sodium selenite and doxorubicin prodrug Ac-Phe-Lys-PABC-ADM affects gastric cancer cell apoptosis in xenografted mice. Biomed Res Int 2019:2486783. https:\/\/doi.org\/10.1155\/2019\/2486783","journal-title":"Biomed Res Int"},{"issue":"13","key":"5026_CR43","doi-asserted-by":"publisher","first-page":"3169","DOI":"10.3390\/cancers13133169","volume":"13","author":"K Doello","year":"2021","unstructured":"Doello K, Mesas C, Qui\u00f1onero F, Perazzoli G, Cabeza L, Prados J, Melguizo C, Ortiz R (2021) The antitumor activity of sodium selenite alone and in combination with gemcitabine in pancreatic cancer: an in vitro and in vivo study. Cancers (Basel) 13(13):3169. https:\/\/doi.org\/10.3390\/cancers13133169","journal-title":"Cancers (Basel)"},{"issue":"1","key":"5026_CR44","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1186\/s12885-022-09965-8","volume":"22","author":"X Liu","year":"2022","unstructured":"Liu X, Jiang M, Pang C, Wang J, Hu L (2022) Sodium selenite inhibits proliferation and metastasis through ROS-mediated NF-\u03baB signaling in renal cell carcinoma. BMC Cancer 22(1):870. https:\/\/doi.org\/10.1186\/s12885-022-09965-8","journal-title":"BMC Cancer"},{"issue":"4","key":"5026_CR45","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1007\/s12253-020-00870-8","volume":"26","author":"G Lendvai","year":"2020","unstructured":"Lendvai G, Szekercz\u00e9s T, Kontsek E, Selvam A, Szakos A, Schaff Z, Bj\u00f6rnstedt M, Kiss A (2020) The effect of methylselenocysteine and sodium selenite treatment on MicroRNA expression in liver cancer cell lines. Pathol Oncol Res 26(4):2669\u20132681. https:\/\/doi.org\/10.1007\/s12253-020-00870-8","journal-title":"Pathol Oncol Res"},{"issue":"8","key":"5026_CR46","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1016\/j.tiv.2009.07.012","volume":"23","author":"V Kr\u00e1lov\u00e1","year":"2009","unstructured":"Kr\u00e1lov\u00e1 V, Brigulov\u00e1 K, Cervinka M, Rudolf E (2009) Antiproliferative and cytotoxic effects of sodium selenite in human colon cancer cells. Toxicol Vitro 23(8):1497\u20131503. https:\/\/doi.org\/10.1016\/j.tiv.2009.07.012","journal-title":"Toxicol Vitro"},{"issue":"11","key":"5026_CR47","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.3390\/nu16111737","volume":"16","author":"S Zhao","year":"2024","unstructured":"Zhao S, Meng Y, Cai W, Luo Q, Gao H, Shen Q, Shi D (2024) Docosahexaenoic acid coordinating with sodium selenite promotes paraptosis in colorectal cancer cells by disrupting the redox homeostasis and activating the MAPK pathway. Nutrients 16(11):1737. https:\/\/doi.org\/10.3390\/nu16111737","journal-title":"Nutrients"},{"key":"5026_CR48","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jtemb.2018.11.009","volume":"52","author":"K Soukupov\u00e1","year":"2019","unstructured":"Soukupov\u00e1 K, Rudolf E (2019) Suppression of proliferation and activation of cell death by sodium selenite involves mitochondria and lysosomes in chemoresistant bladder cancer cells. J Trace Elem Med Biol 52:58\u201367. https:\/\/doi.org\/10.1016\/j.jtemb.2018.11.009","journal-title":"J Trace Elem Med Biol"},{"key":"5026_CR49","doi-asserted-by":"publisher","first-page":"2035682","DOI":"10.1155\/2019\/2035682","volume":"2019","author":"S Tan","year":"2019","unstructured":"Tan S, Mo J, Zhang Z, Huang C, Zou Y, Sun J (2019) Sodium selenite accentuates the therapeutic effect of adriamycin prodrug (PADM) against gastric cancer. Biomed Res Int 2019:2035682. https:\/\/doi.org\/10.1155\/2019\/2035682","journal-title":"Biomed Res Int"},{"key":"5026_CR50","doi-asserted-by":"publisher","unstructured":"Kim JB, Yang EY, Woo J, Kwon H, Lim W, Moon BI (2020) Sodium selenite enhanced the Anti-proliferative effect of MEK-ERK inhibitor in thyroid cancer Cells. In vivo 34(1):185\u2013190 https:\/\/doi.org\/10.21873\/invivo.11760","DOI":"10.21873\/invivo.11760"},{"issue":"5","key":"5026_CR51","doi-asserted-by":"publisher","first-page":"6560","DOI":"10.3892\/mmr.2018.8679","volume":"17","author":"L Yang","year":"2018","unstructured":"Yang L, Cai YS, Xu K, Zhu JL, Li YB, Wu XQ, Sun J, Lu SM, Xu P (2018) Sodium selenite induces apoptosis and inhibits autophagy in human synovial sarcoma cell line SW982 in vitro. Mol Med Rep 17(5):6560\u20136568. https:\/\/doi.org\/10.3892\/mmr.2018.8679","journal-title":"Mol Med Rep"},{"issue":"6","key":"5026_CR52","doi-asserted-by":"publisher","first-page":"4978","DOI":"10.3390\/nu7064978","volume":"7","author":"O Brodin","year":"2015","unstructured":"Brodin O, Eksborg S, Wallenberg M, Asker-Hagelberg C, Larsen EH, Mohlkert D, Lenneby-Helleday C, Jacobsson H, Linder S, Misra S, Bj\u00f6rnstedt M (2015) Pharmacokinetics and toxicity of sodium selenite in the treatment of patients with carcinoma in a phase I clinical trial: the SECAR study. Nutrients 7(6):4978\u20134994. https:\/\/doi.org\/10.3390\/nu7064978","journal-title":"Nutrients"},{"issue":"2","key":"5026_CR53","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.tiv.2011.12.010","volume":"26","author":"V Kr\u00e1lov\u00e1","year":"2012","unstructured":"Kr\u00e1lov\u00e1 V, Bene\u0161ov\u00e1 S, Cervinka M, Rudolf E (2012) Selenite-induced apoptosis and autophagy in colon cancer cells. Toxicol Vitro 26(2):258\u2013268. https:\/\/doi.org\/10.1016\/j.tiv.2011.12.010","journal-title":"Toxicol Vitro"},{"key":"5026_CR54","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.cbi.2017.07.020","volume":"275","author":"X Zheng","year":"2017","unstructured":"Zheng X, Xu W, Sun R, Yin H, Dong C, Zeng H (2017) Synergism between thioredoxin reductase inhibitor Ethaselen and sodium selenite in inhibiting proliferation and inducing death of human non-small cell lung cancer cells. Chem Biol Interact 275:74\u201385. https:\/\/doi.org\/10.1016\/j.cbi.2017.07.020","journal-title":"Chem Biol Interact"},{"key":"5026_CR55","doi-asserted-by":"publisher","first-page":"104360","DOI":"10.1016\/j.phrs.2019.104360","volume":"147","author":"X Wu","year":"2019","unstructured":"Wu X, Zhao G, He Y, Wang W, Yang CS, Zhang J (2019) Pharmacological mechanisms of the anticancer action of sodium selenite against peritoneal cancer in mice. Pharmacol Res 147:104360. https:\/\/doi.org\/10.1016\/j.phrs.2019.104360","journal-title":"Pharmacol Res"},{"key":"5026_CR56","doi-asserted-by":"publisher","first-page":"127582","DOI":"10.1016\/j.jtemb.2024.127582","volume":"87","author":"Y Wang","year":"2025","unstructured":"Wang Y, Qi L, Guo S, Jia Y, Wang R, Lv C, Zeng Q, Gao Y, Wang T, Li Q (2025) Sodium selenite inhibits the growth of cervical cancer cells through the PI3K\/AKT pathway. J Trace Elem Med Biol 87:127582. https:\/\/doi.org\/10.1016\/j.jtemb.2024.127582","journal-title":"J Trace Elem Med Biol"},{"issue":"19","key":"5026_CR57","doi-asserted-by":"publisher","first-page":"10646","DOI":"10.3390\/ijms221910646","volume":"22","author":"L Larrouqu\u00e8re","year":"2021","unstructured":"Larrouqu\u00e8re L, Berthier S, Chovelon B, Garrel C, Vacchina V, Paucot H, Boutonnat J, Faure P, Hazane-Puch F (2021) Preclinical evaluation of sodium selenite in mice: toxicological and tumor regression studies after striatum implantation of human glioblastoma stem cells. Int J Mol Sci 22(19):10646. https:\/\/doi.org\/10.3390\/ijms221910646","journal-title":"Int J Mol Sci"},{"issue":"3","key":"5026_CR58","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.3892\/or.2015.4484","volume":"35","author":"Y Yang","year":"2016","unstructured":"Yang Y, Luo H, Hui K, Ci Y, Shi K, Chen G, Shi L, Xu C (2016) Selenite-induced autophagy antagonizes apoptosis in colorectal cancer cells in vitro and in vivo. Oncol Rep 35(3):1255\u20131264. https:\/\/doi.org\/10.3892\/or.2015.4484","journal-title":"Oncol Rep"},{"issue":"4","key":"5026_CR59","doi-asserted-by":"publisher","first-page":"490","DOI":"10.2174\/1871520615666150819095426","volume":"16","author":"F Hazane-Puch","year":"2016","unstructured":"Hazane-Puch F, Arnaud J, Trocm\u00e9 C, Faure P, Laporte F, Champelovier P (2016) Sodium selenite decreased HDAC Activity, cell proliferation and induced apoptosis in three human glioblastoma cells. Anticancer Agents Med Chem 16(4):490\u2013500. https:\/\/doi.org\/10.2174\/1871520615666150819095426","journal-title":"Anticancer Agents Med Chem"},{"issue":"9","key":"5026_CR60","doi-asserted-by":"publisher","first-page":"e0257298","DOI":"10.1371\/journal.pone.0257298","volume":"16","author":"J Woo","year":"2021","unstructured":"Woo J, Kim JB, Cho T, Yoo EH, Moon BI, Kwon H, Lim W (2021) Selenium inhibits growth of trastuzumab-resistant human breast cancer cells via downregulation of Akt and beclin-1. PLoS ONE 16(9):e0257298. https:\/\/doi.org\/10.1371\/journal.pone.0257298","journal-title":"PLoS ONE"},{"issue":"2","key":"5026_CR61","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ccr.2004.06.022","volume":"6","author":"Y Nagata","year":"2004","unstructured":"Nagata Y, Lan KH, Zhou X, Tan M, Esteva FJ, Sahin AA, Klos KS, Li P, Monia BP, Nguyen NT, Hortobagyi GN, Hung MC, Yu D (2004) PTEN activation contributes to tumor Inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients. Cancer Cell 6(2):117\u2013127. https:\/\/doi.org\/10.1016\/j.ccr.2004.06.022","journal-title":"Cancer Cell"},{"key":"5026_CR62","doi-asserted-by":"publisher","first-page":"b5396","DOI":"10.1136\/bmj.b5396","volume":"340","author":"M Torres Lacomba","year":"2010","unstructured":"Torres Lacomba M, Yuste S\u00e1nchez MJ, Zapico Go\u00f1i A, Prieto Merino D, Mayoral del Moral O, Cerezo T\u00e9llez E, Minayo Mogoll\u00f3n E (2010) Effectiveness of early physiotherapy to prevent lymphoedema after surgery for breast cancer: randomised, single blinded, clinical trial. BMJ 340:b5396. https:\/\/doi.org\/10.1136\/bmj.b5396","journal-title":"BMJ"},{"issue":"4","key":"5026_CR63","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1097\/00045391-200007040-00008","volume":"7","author":"RG Kasseroller","year":"2000","unstructured":"Kasseroller RG, Schrauzer GN (2000) Treatment of secondary lymphedema of the arm with physical decongestive therapy and sodium selenite: a review. Am J Ther 7(4):273\u2013279. https:\/\/doi.org\/10.1097\/00045391-200007040-00008","journal-title":"Am J Ther"},{"issue":"1","key":"5026_CR64","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/s0360-3016(02)04390-0","volume":"56","author":"O Micke","year":"2003","unstructured":"Micke O, Bruns F, M\u00fccke R, Sch\u00e4fer U, Glatzel M, DeVries AF, Sch\u00f6nekaes K, Kisters K, B\u00fcntzel J (2003) Selenium in the treatment of radiation-associated secondary lymphedema. Int J Radiat Oncol Biol Phys 56(1):40\u201349. https:\/\/doi.org\/10.1016\/s0360-3016(02)04390-0","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"5026_CR65","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.3390\/cancers3011285","volume":"3","author":"AL Ortega","year":"2011","unstructured":"Ortega AL, Mena S, Estrela JM (2011) Glutathione in cancer cell death. Cancers (Basel) 3(1):1285\u20131310. https:\/\/doi.org\/10.3390\/cancers3011285","journal-title":"Cancers (Basel)"},{"issue":"5","key":"5026_CR66","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.3390\/nu11051021","volume":"11","author":"HW Han","year":"2019","unstructured":"Han HW, Yang EJ, Lee SM (2019) Sodium selenite alleviates breast Cancer-Related lymphedema independent of antioxidant defense system. Nutrients 11(5):1021. https:\/\/doi.org\/10.3390\/nu11051021","journal-title":"Nutrients"},{"issue":"9","key":"5026_CR67","doi-asserted-by":"publisher","first-page":"3253","DOI":"10.3390\/nu13093253","volume":"13","author":"H Lee","year":"2021","unstructured":"Lee H, Lee B, Kim Y, Min S, Yang E, Lee S (2021) Effects of sodium selenite injection on serum metabolic profiles in women diagnosed with breast Cancer-Related Lymphedema-Secondary analysis of a randomized Placebo-Controlled trial using global metabolomics. Nutrients 13(9):3253. https:\/\/doi.org\/10.3390\/nu13093253","journal-title":"Nutrients"},{"key":"5026_CR68","doi-asserted-by":"publisher","first-page":"135","DOI":"10.31857\/S0026898422010062","volume-title":"Jan-Feb","author":"VN Mal\u2019tseva","year":"2022","unstructured":"Mal\u2019tseva VN, Goltyaev MV, Novoselov SV, Varlamova EG (2022) \u2013146 [Effects of Sodium Selenite and Dithiothreitol on Expression of Endoplasmic Reticulum Selenoproteins and Apoptosis Markers in MSF7 Breast Adenocarcinoma Cells] 56: 135. 1https:\/\/doi.org\/10.31857\/S0026898422010062"},{"key":"5026_CR69","doi-asserted-by":"publisher","first-page":"109651","DOI":"10.1016\/j.cbi.2021.109651","volume":"349","author":"L Cao","year":"2021","unstructured":"Cao L, Zhang J, Du Y, Sun M, Xiang Y, Sheng Y, Ren X, Shao J (2021) Selenite induced breast cancer MCF7 cells apoptosis through Endoplasmic reticulum stress and oxidative stress pathway. Chem Biol Interact 349:109651. https:\/\/doi.org\/10.1016\/j.cbi.2021.109651","journal-title":"Chem Biol Interact"},{"issue":"3","key":"5026_CR70","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1002\/jcp.26783","volume":"234","author":"T Zhang","year":"2019","unstructured":"Zhang T, Zhao G, Zhu X, Jiang K, Wu H, Deng G, Qiu C (2019) Sodium selenite induces apoptosis via ROS-mediated NF-\u03baB signaling and activation of the Bax-caspase-9-caspase-3 axis in 4T1 cells. J Cell Physiol 234(3):2511\u20132522. https:\/\/doi.org\/10.1002\/jcp.26783","journal-title":"J Cell Physiol"},{"issue":"2","key":"5026_CR71","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1002\/1097-4644(20001101)79:2<282::aid-jcb110>3.0.co;2-v","volume":"79","author":"A Stoica","year":"2000","unstructured":"Stoica A, Pentecost E, Martin MB (2000) Effects of selenite on Estrogen receptor-alpha expression and activity in MCF-7 breast cancer cells. J Cell Biochem 79(2):282\u2013292. https:\/\/doi.org\/10.1002\/1097-4644(20001101)79:2%3C282::aid-jcb110%3E3.0.co;2-v","journal-title":"J Cell Biochem"},{"issue":"3","key":"5026_CR72","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.3390\/ijms22031009","volume":"22","author":"D Radomska","year":"2021","unstructured":"Radomska D, Czarnomysy R, Radomski D, Bielawski K (2021) Selenium compounds as novel potential anticancer agents. Int J Mol Sci 22(3):1009. https:\/\/doi.org\/10.3390\/ijms22031009","journal-title":"Int J Mol Sci"},{"issue":"2","key":"5026_CR73","doi-asserted-by":"publisher","first-page":"367","DOI":"10.3390\/pharmaceutics14020367","volume":"14","author":"MA Mar\u0107","year":"2022","unstructured":"Mar\u0107 MA, Dom\u00ednguez-\u00c1lvarez E, Latacz G, Doroz-P\u0142onka A, Sanmart\u00edn C, Spengler G, Handzlik J (2022) Pharmaceutical and safety profile evaluation of novel Selenocompounds with noteworthy anticancer activity. Pharmaceutics 14(2):367. https:\/\/doi.org\/10.3390\/pharmaceutics14020367","journal-title":"Pharmaceutics"},{"issue":"18","key":"5026_CR74","doi-asserted-by":"publisher","first-page":"4563","DOI":"10.3390\/cancers13184563","volume":"13","author":"N Szemer\u00e9di","year":"2021","unstructured":"Szemer\u00e9di N, Dobiasov\u00e1 S, Salard\u00f3n-Jim\u00e9nez N, Kincses A, Nov\u00e9 M, Habibullah G, Sevilla-Hern\u00e1ndez C, Benito-Lama M, Alonso-Mart\u00ednez FJ, Viktorov\u00e1 J, Spengler G, Dom\u00ednguez-\u00c1lvarez E (2021) Cyano- and Ketone-Containing selenoesters as Multi-Target compounds against resistant cancers. Cancers (Basel) 13(18):4563. https:\/\/doi.org\/10.3390\/cancers13184563","journal-title":"Cancers (Basel)"},{"issue":"1","key":"5026_CR75","doi-asserted-by":"publisher","first-page":"6548","DOI":"10.1038\/s41598-022-10311-y","volume":"12","author":"S Dobiasov\u00e1","year":"2022","unstructured":"Dobiasov\u00e1 S, Szemer\u00e9di N, Ku\u010derov\u00e1 D, Kouck\u00e1 K, V\u00e1clav\u00edkov\u00e1 R, Gbelcov\u00e1 H, Ruml T, Dom\u00ednguez-\u00c1lvarez E, Spengler G, Viktorov\u00e1 J (2022) Ketone-selenoesters as potential anticancer and multidrug resistance modulation agents in 2D and 3D ovarian and breast cancer in vitro models. Sci Rep 12(1):6548. https:\/\/doi.org\/10.1038\/s41598-022-10311-y","journal-title":"Sci Rep"},{"issue":"4","key":"5026_CR76","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.bmcl.2017.01.033","volume":"27","author":"M Gajd\u00e1cs","year":"2017","unstructured":"Gajd\u00e1cs M, Spengler G, Sanmart\u00edn C, Mar\u0107 MA, Handzlik J, Dom\u00ednguez-\u00c1lvarez E (2017) Selenoesters and selenoanhydrides as novel multidrug resistance reversing agents: A confirmation study in a colon cancer MDR cell line. Bioorg Med Chem Lett 27(4):797\u2013802. https:\/\/doi.org\/10.1016\/j.bmcl.2017.01.033","journal-title":"Bioorg Med Chem Lett"},{"issue":"2","key":"5026_CR77","doi-asserted-by":"publisher","first-page":"336","DOI":"10.3390\/molecules24020336","volume":"24","author":"G Spengler","year":"2019","unstructured":"Spengler G, Gajd\u00e1cs M, Mar\u0107 MA, Dom\u00ednguez-\u00c1lvarez E, Sanmart\u00edn C (2019) Organoselenium compounds as novel adjuvants of chemotherapy drugs-A promising approach to fight cancer drug resistance. Molecules 24(2):336. https:\/\/doi.org\/10.3390\/molecules24020336","journal-title":"Molecules"},{"issue":"17","key":"5026_CR78","doi-asserted-by":"publisher","first-page":"4304","DOI":"10.3390\/cancers14174304","volume":"14","author":"D Radomska","year":"2022","unstructured":"Radomska D, Czarnomysy R, Szymanowska A, Radomski D, Dom\u00ednguez-\u00c1lvarez E, Bielawska A, Bielawski K (2022) Novel selenoesters as a potential tool in Triple-Negative breast cancer treatment. Cancers (Basel) 14(17):4304. https:\/\/doi.org\/10.3390\/cancers14174304","journal-title":"Cancers (Basel)"},{"issue":"3","key":"5026_CR79","doi-asserted-by":"publisher","first-page":"865","DOI":"10.3390\/nu12030865","volume":"12","author":"DG Pons","year":"2020","unstructured":"Pons DG, Moran C, Alorda-Clara M, Oliver J, Roca P, Sastre-Serra J (2020) Micronutrients selenomethionine and selenocysteine modulate the redox status of MCF-7 breast cancer cells. Nutrients 12(3):865. https:\/\/doi.org\/10.3390\/nu12030865","journal-title":"Nutrients"},{"issue":"2","key":"5026_CR80","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/0006-2952(93)90080-G","volume":"45","author":"L Yan","year":"1993","unstructured":"Yan L, Spallholz JE (1993) Generation of reactive oxygen species from the reaction of selenium compounds with thiols and mammary tumor cells. Biochem Pharmacol 45(2):429\u2013437","journal-title":"Biochem Pharmacol"},{"key":"5026_CR81","unstructured":"Jackson MI, Combs GF (2012) In: Hatfield DL, Berry MJ, Gladyshev V.N., (eds) Selenium: its molecular biology and role in human health. Springer, Berlin\/Heidelberg, Germany"},{"issue":"9","key":"5026_CR82","doi-asserted-by":"publisher","first-page":"748","DOI":"10.7150\/ijms.12177","volume":"12","author":"CH Guo","year":"2015","unstructured":"Guo CH, Hsia S, Shih MY, Hsieh FC, Chen PC (2015) Effects of selenium yeast on oxidative Stress, growth Inhibition, and apoptosis in human breast cancer cells. Int J Med Sci 12(9):748\u2013758. https:\/\/doi.org\/10.7150\/ijms.12177","journal-title":"Int J Med Sci"},{"issue":"2","key":"5026_CR83","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/(sici)1097-0215(19970422)74:2<193:aid-ijc10>3.0.co;2-f","volume":"74","author":"G Toffoli","year":"1997","unstructured":"Toffoli G, Cernigoi C, Russo A, Gallo A, Bagnoli M, Boiocchi M (1997) Overexpression of folate binding protein in ovarian cancers. Int J Cancer 74(2):193\u2013198. https:\/\/doi.org\/10.1002\/(sici)1097-0215(19970422)74:2%3C193:aid-ijc10%3E3.0.co;2-f","journal-title":"Int J Cancer"},{"issue":"12","key":"5026_CR84","first-page":"3396","volume":"52","author":"SD Weitman","year":"1992","unstructured":"Weitman SD, Lark RH, Coney LR, Fort DW, Frasca V, Zurawski VR Jr, Kamen BA (1992) Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues. Cancer Res 52(12):3396\u20133401","journal-title":"Cancer Res"},{"key":"5026_CR85","doi-asserted-by":"publisher","unstructured":"Nunez MI, Behrens C, Woods DM, Lin H, Suraokar M, Kadara H, Hofstetter W, Kalhor N, Lee JJ, Franklin W, Stewart DJ, Wistuba II (2012) High expression of folate receptor alpha in lung cancer correlates with adenocarcinoma histology and EGFR [corrected] mutation. J Thorac Oncol 7(5):833\u2009\u2013\u200940 https:\/\/doi.org\/10.1097\/JTO.0b013e31824de09c. Erratum in: J Thorac Oncol. 2012;7(6):1065","DOI":"10.1097\/JTO.0b013e31824de09c"},{"issue":"2","key":"5026_CR86","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3390\/antiox9020138","volume":"9","author":"S Khandelwal","year":"2020","unstructured":"Khandelwal S, Boylan M, Kirsch G, Spallholz JE, Gollahon LS (2020) Investigating the potential of conjugated selenium redox folic acid as a treatment for triple negative breast cancer. Antioxid (Basel) 9(2):138. https:\/\/doi.org\/10.3390\/antiox9020138","journal-title":"Antioxid (Basel)"},{"issue":"4","key":"5026_CR87","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1158\/1078-0432.CCR-07-4037","volume":"14","author":"H Hu","year":"2008","unstructured":"Hu H, Li GX, Wang L, Watts J, Combs GF Jr, L\u00fc J (2008) Methylseleninic acid enhances taxane drug efficacy against human prostate cancer and down-regulates antiapoptotic proteins Bcl-XL and survivin. Clin Cancer Res 14(4):1150\u20131158. https:\/\/doi.org\/10.1158\/1078-0432.CCR-07-4037","journal-title":"Clin Cancer Res"},{"issue":"6","key":"5026_CR88","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1158\/1078-0432.CCR-04-2084","volume":"11","author":"H Hu","year":"2005","unstructured":"Hu H, Jiang C, Ip C, Rustum YM, L\u00fc J (2005) Methylseleninic acid potentiates apoptosis induced by chemotherapeutic drugs in androgen-independent prostate cancer cells. Clin Cancer Res 11(6):2379\u20132388. https:\/\/doi.org\/10.1158\/1078-0432.CCR-04-2084","journal-title":"Clin Cancer Res"},{"issue":"5A","key":"5026_CR89","first-page":"3075","volume":"27","author":"S Li","year":"2007","unstructured":"Li S, Zhou Y, Dong Y, Ip C (2007) Doxorubicin and selenium cooperatively induce Fas signaling in the absence of Fas\/Fas ligand interaction. Anticancer Res 27(5A):3075\u20133082","journal-title":"Anticancer Res"},{"issue":"3","key":"5026_CR90","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1158\/1535-7163.MCT-06-0643","volume":"6","author":"S Li","year":"2007","unstructured":"Li S, Zhou Y, Wang R, Zhang H, Dong Y, Ip C (2007) Selenium sensitizes MCF-7 breast cancer cells to doxorubicin-induced apoptosis through modulation of phospho-Akt and its downstream substrates. Mol Cancer Ther 6(3):1031\u20131038. https:\/\/doi.org\/10.1158\/1535-7163.MCT-06-0643","journal-title":"Mol Cancer Ther"},{"issue":"12","key":"5026_CR91","doi-asserted-by":"publisher","first-page":"6614","DOI":"10.3390\/ijms22126614","volume":"22","author":"EG Varlamova","year":"2021","unstructured":"Varlamova EG, Turovsky EA, THE MAIN CYTOTOXIC EFFECTS OF METHYLSELENINIC, ACID ON VARIOUS CANCER CELLS (2021) Int J Mol Sci 22(12):6614. https:\/\/doi.org\/10.3390\/ijms22126614","journal-title":"Int J Mol Sci"},{"issue":"2","key":"5026_CR92","doi-asserted-by":"publisher","first-page":"e31539","DOI":"10.1371\/journal.pone.0031539","volume":"7","author":"Y Qi","year":"2012","unstructured":"Qi Y, Fu X, Xiong Z, Zhang H, Hill SM, Rowan BG, Dong Y (2012) Methylseleninic acid enhances Paclitaxel efficacy for the treatment of triple-negative breast cancer. PLoS ONE 7(2):e31539. https:\/\/doi.org\/10.1371\/journal.pone.0031539","journal-title":"PLoS ONE"},{"key":"5026_CR93","doi-asserted-by":"publisher","first-page":"144884","DOI":"10.1016\/j.gene.2020.144884","volume":"755","author":"MV Goltyaev","year":"2020","unstructured":"Goltyaev MV, Mal\u2019tseva VN, Varlamova EG (2020) Expression of ER-resident selenoproteins and activation of cancer cells apoptosis mechanisms under ER-stress conditions caused by Methylseleninic acid. Gene 755:144884. https:\/\/doi.org\/10.1016\/j.gene.2020.144884","journal-title":"Gene"},{"issue":"6","key":"5026_CR94","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1177\/1933719118815582","volume":"26","author":"C Qiu","year":"2019","unstructured":"Qiu C, Zhang T, Zhu X, Qiu J, Jiang K, Zhao G, Wu H, Deng G (2019) Methylseleninic Acid Suppresses Breast Cancer Growth via the JAK2\/STAT3 Pathway. Reprod Sci 26(6):829\u2013838. . Epub 2018 Dec 9. Erratum in: Reprod Sci. 2021;28(2):614 https:\/\/doi.org\/10.1007\/s43032-020-00353-w","journal-title":"Reprod Sci"},{"issue":"1","key":"5026_CR95","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s12011-015-0387-3","volume":"169","author":"Y Liu","year":"2016","unstructured":"Liu Y, Li W, Guo M, Li C, Qiu C (2016) Protective role of selenium compounds on the Proliferation, Apoptosis, and angiogenesis of a canine breast cancer cell line. Biol Trace Elem Res 169(1):86\u201393. https:\/\/doi.org\/10.1007\/s12011-015-0387-3","journal-title":"Biol Trace Elem Res"},{"issue":"2","key":"5026_CR96","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s12011-015-0554-6","volume":"171","author":"W Li","year":"2016","unstructured":"Li W, Guo M, Liu Y, Mu W, Deng G, Li C, Qiu C (2016) Selenium induces an Anti-tumor effect via inhibiting intratumoral angiogenesis in a mouse model of transplanted canine mammary tumor cells. Biol Trace Elem Res 171(2):371\u2013379. https:\/\/doi.org\/10.1007\/s12011-015-0554-6","journal-title":"Biol Trace Elem Res"},{"issue":"1\u20134","key":"5026_CR97","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/biof.5520140122","volume":"14","author":"E Unni","year":"2001","unstructured":"Unni E, Singh U, Ganther HE, Sinha R (2001) Se-methylselenocysteine activates caspase-3 in mouse mammary epithelial tumor cells in vitro. BioFactors 14(1\u20134):169\u2013177. https:\/\/doi.org\/10.1002\/biof.5520140122","journal-title":"BioFactors"},{"issue":"8","key":"5026_CR98","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1093\/carcin\/18.8.1541","volume":"18","author":"R Sinha","year":"1997","unstructured":"Sinha R, Medina D (1997) Inhibition of cdk2 kinase activity by methylselenocysteine in synchronized mouse mammary epithelial tumor cells. Carcinogenesis 18(8):1541\u20131547. https:\/\/doi.org\/10.1093\/carcin\/18.8.1541","journal-title":"Carcinogenesis"},{"issue":"5","key":"5026_CR99","doi-asserted-by":"publisher","first-page":"R699","DOI":"10.1186\/bcr1276","volume":"7","author":"E Unni","year":"2005","unstructured":"Unni E, Koul D, Yung WK, Sinha R (2005) Se-methylselenocysteine inhibits phosphatidylinositol 3-kinase activity of mouse mammary epithelial tumor cells in vitro. Breast Cancer Res 7(5):R699\u2013707. https:\/\/doi.org\/10.1186\/bcr1276","journal-title":"Breast Cancer Res"},{"issue":"1","key":"5026_CR100","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/s0092-8674(02)00961-3","volume":"111","author":"L Fu","year":"2002","unstructured":"Fu L, Pelicano H, Liu J, Huang P, Lee C (2002) The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell 111(1):41\u201350. https:\/\/doi.org\/10.1016\/s0092-8674(02)00961-3","journal-title":"Cell"},{"issue":"6740","key":"5026_CR101","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/22118","volume":"400","author":"B Zheng","year":"1999","unstructured":"Zheng B, Larkin DW, Albrecht U, Sun ZS, Sage M, Eichele G, Lee CC, Bradley A (1999) The mPer2 gene encodes a functional component of the mammalian circadian clock. Nature 400(6740):169\u2013173. https:\/\/doi.org\/10.1038\/22118","journal-title":"Nature"},{"issue":"4","key":"5026_CR102","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s10552-005-9003-8","volume":"17","author":"CC Lee","year":"2006","unstructured":"Lee CC (2006) Tumor suppression by the mammalian period genes. Cancer Causes Control 17(4):525\u2013530. https:\/\/doi.org\/10.1007\/s10552-005-9003-8","journal-title":"Cancer Causes Control"},{"issue":"57","key":"5026_CR103","doi-asserted-by":"publisher","first-page":"7916","DOI":"10.1038\/sj.onc.1210585","volume":"26","author":"S Gery","year":"2007","unstructured":"Gery S, Virk RK, Chumakov K, Yu A, Koeffler HP (2007) The clock gene Per2 links the circadian system to the Estrogen receptor. Oncogene 26(57):7916\u20137920. https:\/\/doi.org\/10.1038\/sj.onc.1210585","journal-title":"Oncogene"},{"issue":"4","key":"5026_CR104","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s10552-005-9010-9","volume":"17","author":"S Davis","year":"2006","unstructured":"Davis S, Mirick DK (2006) Circadian disruption, shift work and the risk of cancer: a summary of the evidence and studies in Seattle. Cancer Causes Control 17(4):539\u2013545. https:\/\/doi.org\/10.1007\/s10552-005-9010-9","journal-title":"Cancer Causes Control"},{"issue":"4","key":"5026_CR105","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s10552-005-9006-5","volume":"17","author":"J Hansen","year":"2006","unstructured":"Hansen J (2006) Risk of breast cancer after night- and shift work: current evidence and ongoing studies in Denmark. Cancer Causes Control 17(4):531\u2013537. https:\/\/doi.org\/10.1007\/s10552-005-9006-5","journal-title":"Cancer Causes Control"},{"issue":"20","key":"5026_CR106","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1093\/jnci\/93.20.1563","volume":"93","author":"ES Schernhammer","year":"2001","unstructured":"Schernhammer ES, Laden F, Speizer FE, Willett WC, Hunter DJ, Kawachi I, Colditz GA (2001) Rotating night shifts and risk of breast cancer in women participating in the nurses\u2019 health study. J Natl Cancer Inst 93(20):1563\u20131568. https:\/\/doi.org\/10.1093\/jnci\/93.20.1563","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"5026_CR107","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.tips.2017.11.003","volume":"39","author":"H Wang","year":"2018","unstructured":"Wang H, Mu X, He H, Zhang XD (2018) Cancer radiosensitizers. Trends Pharmacol Sci 39(1):24\u201348. https:\/\/doi.org\/10.1016\/j.tips.2017.11.003","journal-title":"Trends Pharmacol Sci"},{"issue":"5","key":"5026_CR108","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1080\/21691401.2017.1347941","volume":"46","author":"F Chen","year":"2018","unstructured":"Chen F, Zhang XH, Hu XD, Liu PD, Zhang HQ (2018) The effects of combined selenium nanoparticles and radiation therapy on breast cancer cells in vitro. Artif Cells Nanomed Biotechnol 46(5):937\u2013948. https:\/\/doi.org\/10.1080\/21691401.2017.1347941","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"31","key":"5026_CR109","doi-asserted-by":"publisher","first-page":"25857","DOI":"10.1021\/acsami.7b07167","volume":"9","author":"Y Yang","year":"2017","unstructured":"Yang Y, Xie Q, Zhao Z, He L, Chan L, Liu Y, Chen Y, Bai M, Pan T, Qu Y, Ling L, Chen T (2017) Functionalized selenium nanosystem as radiation sensitizer of 125I seeds for precise cancer therapy. ACS Appl Mater Interfaces 9(31):25857\u201325869. https:\/\/doi.org\/10.1021\/acsami.7b07167","journal-title":"ACS Appl Mater Interfaces"},{"issue":"10","key":"5026_CR110","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1002\/ijc.30235","volume":"139","author":"G Yang","year":"2016","unstructured":"Yang G, Li W, Jiang H et al (2016) Low-dose radiation May be a novel approach to enhance the effectiveness of cancer therapeutics. Int J Cancer 139(10):2157\u20132168. https:\/\/doi.org\/10.1002\/ijc.30235","journal-title":"Int J Cancer"},{"issue":"5","key":"5026_CR111","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1038\/cdd.2014.24","volume":"21","author":"R Lall","year":"2014","unstructured":"Lall R, Ganapathy S, Yang M et al (2014) Low-dose radiation exposure induces a HIF-1-mediated adaptive and protective metabolic response. Cell Death Differ 21(5):836\u2013844. https:\/\/doi.org\/10.1038\/cdd.2014.24","journal-title":"Cell Death Differ"},{"issue":"2","key":"5026_CR112","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jconrel.2012.07.010","volume":"164","author":"IK Kwon","year":"2012","unstructured":"Kwon IK, Lee SC, Han B, Park K (2012) Analysis on the current status of targeted drug delivery to tumors. J Control Release 164(2):108\u2013114. https:\/\/doi.org\/10.1016\/j.jconrel.2012.07.010","journal-title":"J Control Release"},{"issue":"1","key":"5026_CR113","doi-asserted-by":"publisher","first-page":"350","DOI":"10.3109\/21691401.2014.951722","volume":"44","author":"Y Xu","year":"2016","unstructured":"Xu Y, Meng H (2016) Paclitaxel-loaded stealth liposomes: Development, characterization, pharmacokinetics, and biodistribution. Artif Cells Nanomed Biotechnol 44(1):350\u2013355. https:\/\/doi.org\/10.3109\/21691401.2014.951722","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"9","key":"5026_CR114","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.2217\/nnm-2017-0024","volume":"12","author":"F Maiyo","year":"2017","unstructured":"Maiyo F, Singh M (2017) Selenium nanoparticles: potential in cancer gene and drug delivery. Nanomed (Lond) 12(9):1075\u20131089. https:\/\/doi.org\/10.2217\/nnm-2017-0024","journal-title":"Nanomed (Lond)"},{"issue":"21","key":"5026_CR115","doi-asserted-by":"publisher","first-page":"7290","DOI":"10.3390\/molecules27217290","volume":"27","author":"S Menon","year":"2022","unstructured":"Menon S, Jayakodi S, Yadav KK, Somu P, Isaq M, Shanmugam VK, Chaitanyakumar A, Basavegowda N (2022) Preparation of Paclitaxel-Encapsulated Bio-Functionalized selenium nanoparticles and evaluation of their efficacy against cervical cancer. Molecules 27(21):7290. https:\/\/doi.org\/10.3390\/molecules27217290","journal-title":"Molecules"},{"issue":"13","key":"5026_CR116","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.3390\/cells13131102","volume":"13","author":"EG Varlamova","year":"2024","unstructured":"Varlamova EG (2024) Molecular mechanisms of the therapeutic effect of selenium nanoparticles in hepatocellular carcinoma. Cells 13(13):1102. https:\/\/doi.org\/10.3390\/cells13131102","journal-title":"Cells"},{"key":"5026_CR117","doi-asserted-by":"publisher","first-page":"127620","DOI":"10.1016\/j.jtemb.2025.127620","volume":"88","author":"EG Varlamova","year":"2025","unstructured":"Varlamova EG (2025) Selenium-containing compounds, selenium nanoparticles and selenoproteins in the prevention and treatment of lung cancer. J Trace Elem Med Biol 88:127620. https:\/\/doi.org\/10.1016\/j.jtemb.2025.127620","journal-title":"J Trace Elem Med Biol"},{"issue":"12","key":"5026_CR118","doi-asserted-by":"publisher","first-page":"6641","DOI":"10.3390\/ijms23126641","volume":"23","author":"EG Varlamova","year":"2022","unstructured":"Varlamova EG, Goltyaev MV, Simakin AV, Gudkov SV, Turovsky EA (2022) Comparative analysis of the cytotoxic effect of a complex of selenium nanoparticles doped with Sorafenib, naked selenium nanoparticles, and Sorafenib on human hepatocyte carcinoma HepG2 cells. Int J Mol Sci 23(12):6641. https:\/\/doi.org\/10.3390\/ijms23126641","journal-title":"Int J Mol Sci"},{"issue":"13","key":"5026_CR119","doi-asserted-by":"publisher","first-page":"10547","DOI":"10.3390\/ijms241310547","volume":"24","author":"MV Goltyaev","year":"2023","unstructured":"Goltyaev MV, Varlamova EG (2023) The role of selenium nanoparticles in the treatment of liver pathologies of various natures. Int J Mol Sci 24(13):10547. https:\/\/doi.org\/10.3390\/ijms241310547","journal-title":"Int J Mol Sci"},{"issue":"23","key":"5026_CR120","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.3390\/cells12232723","volume":"12","author":"EG Varlamova","year":"2023","unstructured":"Varlamova EG, Goltyaev MV, Rogachev VV, Gudkov SV, Karaduleva EV, Turovsky EA (2023) Antifibrotic effect of Selenium-Containing nanoparticles on a model of TAA-Induced liver fibrosis. Cells 12(23):2723. https:\/\/doi.org\/10.3390\/cells12232723","journal-title":"Cells"},{"issue":"15","key":"5026_CR121","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.2174\/1871520622666220215122756","volume":"22","author":"D Nath","year":"2022","unstructured":"Nath D, Kaur L, Sohal HS, Malhi DS, Garg S, Thakur D (2022) Application of selenium nanoparticles in localized drug targeting for cancer therapy. Anticancer Agents Med Chem 22(15):2715\u20132725. https:\/\/doi.org\/10.2174\/1871520622666220215122756","journal-title":"Anticancer Agents Med Chem"},{"issue":"4","key":"5026_CR122","doi-asserted-by":"publisher","first-page":"e22989","DOI":"10.1002\/jbt.22989","volume":"36","author":"AA Mohamed","year":"2022","unstructured":"Mohamed AA, Zaghloul RA, Abdelghany AM, El Gayar AM (2022) Selenium nanoparticles and Quercetin suppress thioacetamide-induced hepatocellular carcinoma in rats: Attenuation of inflammation involvement. J Biochem Mol Toxicol 36(4):e22989. https:\/\/doi.org\/10.1002\/jbt.22989","journal-title":"J Biochem Mol Toxicol"},{"issue":"16","key":"5026_CR123","doi-asserted-by":"publisher","first-page":"19904","DOI":"10.1021\/acsami.3c00219","volume":"15","author":"MP Purohit","year":"2023","unstructured":"Purohit MP, Kar AK, Kumari M, Ghosh D, Patnaik S (2023) Heparin biofunctionalized selenium nanoparticles as potential Antiangiogenic-Chemotherapeutic agents for targeted doxorubicin delivery. ACS Appl Mater Interfaces 15(16):19904\u201319920. https:\/\/doi.org\/10.1021\/acsami.3c00219","journal-title":"ACS Appl Mater Interfaces"},{"issue":"8","key":"5026_CR124","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1080\/21691401.2017.1408020","volume":"46","author":"R Ganassin","year":"2018","unstructured":"Ganassin R, Merker C, Rodrigues MC, Guimar\u00e3es NF, Sodr\u00e9 CSC, Ferreira QDS, da Silva SW, Ombredane AS, Joanitti GA, Py-Daniel KR, Zhang J, Jiang CS, de Morais PC, Mosiniewicz-Szablewska E, Suchocki P, Longo JPF, Meijer J, Estrela-Lopis I, de Azevedo RB, Muehlmann LA (2018) Nanocapsules for the co-delivery of Selol and doxorubicin to breast adenocarcinoma 4T1 cells in vitro. Artif Cells Nanomed Biotechnol 46(8):2002\u20132012. https:\/\/doi.org\/10.1080\/21691401.2017.1408020","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"4","key":"5026_CR125","first-page":"893","volume":"18","author":"P Suchocki","year":"2007","unstructured":"Suchocki P, Misiewicz I, Skupinska K, Waclawek K, Fijalek Z, Kasprzycka-Guttman T (2007) The activity of Selol in multidrug-resistant and sensitive human leukemia cells. Oncol Rep 18(4):893\u2013899","journal-title":"Oncol Rep"},{"issue":"5","key":"5026_CR126","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1016\/j.ejmech.2011.02.048","volume":"46","author":"AZ Mirza","year":"2011","unstructured":"Mirza AZ, Shamshad H (2011) Preparation and characterization of doxorubicin functionalized gold nanoparticles. Eur J Med Chem 46(5):1857\u20131860. https:\/\/doi.org\/10.1016\/j.ejmech.2011.02.048","journal-title":"Eur J Med Chem"},{"issue":"5","key":"5026_CR127","doi-asserted-by":"publisher","first-page":"278","DOI":"10.3390\/md20050278","volume":"20","author":"Y Mi","year":"2022","unstructured":"Mi Y, Zhang J, Tan W, Miao Q, Li Q, Guo Z (2022) Preparation of Doxorubicin-Loaded Carboxymethyl-\u03b2-Cyclodextrin\/Chitosan nanoparticles with Antioxidant, antitumor activities and pH-Sensitive release. Mar Drugs 20(5):278. https:\/\/doi.org\/10.3390\/md20050278","journal-title":"Mar Drugs"},{"issue":"4","key":"5026_CR128","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1080\/21691401.2016.1261033","volume":"45","author":"M Namdari","year":"2017","unstructured":"Namdari M, Eatemadi A (2017) Cardioprotective effects of curcumin-loaded magnetic hydrogel nanocomposite (nanocurcumin) against doxorubicin-induced cardiac toxicity in rat cardiomyocyte cell lines. Artif Cells Nanomed Biotechnol 45(4):731\u2013739. https:\/\/doi.org\/10.1080\/21691401.2016.1261033","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"4","key":"5026_CR129","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.niox.2012.03.006","volume":"26","author":"L Xi","year":"2012","unstructured":"Xi L, Zhu SG, Das A, Chen Q, Durrant D, Hobbs DC, Lesnefsky EJ, Kukreja RC (2012) Dietary inorganic nitrate alleviates doxorubicin cardiotoxicity: mechanisms and implications. Nitric Oxide 26(4):274\u2013284. https:\/\/doi.org\/10.1016\/j.niox.2012.03.006","journal-title":"Nitric Oxide"},{"issue":"7","key":"5026_CR130","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1021\/cb400095v","volume":"8","author":"GR Chamberlain","year":"2013","unstructured":"Chamberlain GR, Tulumello DV, Kelley SO (2013) Targeted delivery of doxorubicin to mitochondria. ACS Chem Biol 8(7):1389\u20131395. https:\/\/doi.org\/10.1021\/cb400095v","journal-title":"ACS Chem Biol"},{"issue":"sup2","key":"5026_CR131","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1080\/21691401.2018.1478423","volume":"46","author":"R Ganassin","year":"2018","unstructured":"Ganassin R, Horst FH, Camargo NS, Chaves SB, Morais PC, Mosiniewicz-Szablewska E, Suchocki P, Figueir\u00f3 Longo JP, Azevedo RB, Muehlmann LA (2018) Selol nanocapsules with a poly(methyl vinyl ether-co-maleic anhydride) shell conjugated to doxorubicin for combinatorial chemotherapy against murine breast adenocarcinoma in vivo. Artif Cells Nanomed Biotechnol 46(sup2):1046\u20131052. https:\/\/doi.org\/10.1080\/21691401.2018.1478423","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"2","key":"5026_CR132","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s12011-019-01730-6","volume":"193","author":"AA Abd-Rabou","year":"2020","unstructured":"Abd-Rabou AA, Ahmed HH, Shalby AB (2020) Selenium overcomes doxorubicin resistance in their Nano-platforms against breast and colon cancers. Biol Trace Elem Res 193(2):377\u2013389. https:\/\/doi.org\/10.1007\/s12011-019-01730-6","journal-title":"Biol Trace Elem Res"},{"issue":"21","key":"5026_CR133","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.2217\/nnm-2017-0189","volume":"12","author":"AP Bidkar","year":"2017","unstructured":"Bidkar AP, Sanpui P, Ghosh SS (2017) Efficient induction of apoptosis in cancer cells by paclitaxel-loaded selenium nanoparticles. Nanomed (Lond) 12(21):2641\u20132651. https:\/\/doi.org\/10.2217\/nnm-2017-0189","journal-title":"Nanomed (Lond)"},{"issue":"29","key":"5026_CR134","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1080\/17435889.2024.2403962","volume":"19","author":"SS Moni","year":"2024","unstructured":"Moni SS, Abdelwahab SI, Mohan S, Riadi Y, Elmobark ME, Areshyi RW, Sofyani HA, Halawi FA, Hakami MQ, Aljahdali IA, Oraibi B, Farasani A, Dawod OY, Alfaifi HA, Alzahrani AH, Jerah AA (2024) Cetuximab-conjugated sodium selenite nanoparticles for doxorubicin targeted delivery against MCF-7 breast cancer cells. Nanomed (Lond) 19(29):2447\u20132462. https:\/\/doi.org\/10.1080\/17435889.2024.2403962","journal-title":"Nanomed (Lond)"},{"key":"5026_CR135","doi-asserted-by":"publisher","first-page":"758482","DOI":"10.3389\/fbioe.2021.758482","volume":"9","author":"Y Yang","year":"2021","unstructured":"Yang Y, Zhang Z, Chen Q, You Y, Li X, Chen T (2021) Functionalized selenium nanoparticles synergizes with Metformin to treat breast cancer cells through regulation of selenoproteins. Front Bioeng Biotechnol 9:758482. https:\/\/doi.org\/10.3389\/fbioe.2021.758482","journal-title":"Front Bioeng Biotechnol"},{"issue":"5","key":"5026_CR136","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1007\/s13346-024-01714-7","volume":"15","author":"A Adibifar","year":"2025","unstructured":"Adibifar A, Salimi M, Rostamkhani N, Karami Z, Agh-Atabay AH, Rostamizadeh K (2025) Folic acid-conjugated bovine serum albumin-coated selenium-ZIF-8 core\/shell nanoparticles for dual target-specific drug delivery in breast cancer. Drug Deliv Transl Res 15(5):1786\u20131799. https:\/\/doi.org\/10.1007\/s13346-024-01714-7","journal-title":"Drug Deliv Transl Res"},{"key":"5026_CR137","doi-asserted-by":"publisher","first-page":"956181","DOI":"10.3389\/fimmu.2022.956181","volume":"13","author":"G Chen","year":"2022","unstructured":"Chen G, Yang F, Fan S, Jin H, Liao K, Li X, Liu GB, Liang J, Zhang J, Xu JF, Pi J (2022) Immunomodulatory roles of selenium nanoparticles: novel arts for potential immunotherapy strategy development. Front Immunol 13:956181. https:\/\/doi.org\/10.3389\/fimmu.2022.956181","journal-title":"Front Immunol"},{"key":"5026_CR138","doi-asserted-by":"publisher","first-page":"105269","DOI":"10.1016\/j.micpath.2021.105269","volume":"161","author":"W Chen","year":"2021","unstructured":"Chen W, Liu Z, Zheng Y, Wei B, Shi J, Shao B et al (2021) Selenium donor restricts the intracellular growth of Mycobacterium tuberculosis through the induction of c-jun-mediated both canonical autophagy and LC3-associated phagocytosis of alveolar macrophages. Microb Pathogen 161:105269. https:\/\/doi.org\/10.1016\/j.micpath.2021.105269","journal-title":"Microb Pathogen"},{"issue":"1","key":"5026_CR139","doi-asserted-by":"publisher","first-page":"43","DOI":"10.32598\/Immunoregulation.4.1.3","volume":"4","author":"Z Agharezaie","year":"2021","unstructured":"Agharezaie Z, Haghighat S, Yazdi MH (2021) Synthetic nano-selenium improving macrophage immune responses treatment of bladder tumor antigens. Immunoregulation 4(1):43\u201352. https:\/\/doi.org\/10.32598\/Immunoregulation.4.1.3","journal-title":"Immunoregulation"},{"key":"5026_CR140","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.bbrep.2017.09.005","volume":"12","author":"PK Gautam","year":"2017","unstructured":"Gautam PK, Kumar S, Tomar MS, Singh RK, Acharya A, Kumar S et al (2017) Selenium nanoparticles induce suppressed function of tumor associated macrophages and inhibit dalton\u2019s lymphoma proliferation. Biochem Biophys Rep 12:172\u2013184. https:\/\/doi.org\/10.1016\/j.bbrep.2017.09.005","journal-title":"Biochem Biophys Rep"},{"issue":"6","key":"5026_CR141","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1007\/s10534-021-00347-4","volume":"34","author":"Y Jia","year":"2021","unstructured":"Jia Y, Zhang L, Liu X, Zhang S, Dai J, Huang J et al (2021) Selenium can regulate the differentiation and immune function of human dendritic cells. Biometals 34(6):1365\u20131379. https:\/\/doi.org\/10.1007\/s10534-021-00347-4","journal-title":"Biometals"},{"issue":"6","key":"5026_CR142","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1111\/1751-7915.12374","volume":"9","author":"E Cremonini","year":"2016","unstructured":"Cremonini E, Zonaro E, Donini M, Lampis S, Boaretti M, Dusi S et al (2016) Biogenic selenium nanoparticles: characterization, antimicrobial activity and effects on human dendritic cells and fibroblasts. Microb Biotechnol 9(6):758\u2013771. https:\/\/doi.org\/10.1111\/1751-7915.12374","journal-title":"Microb Biotechnol"},{"issue":"2","key":"5026_CR143","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15171\/ijb.1056","volume":"13","author":"MH Yazdi","year":"2015","unstructured":"Yazdi MH, Mahdavi M, Faghfuri E, Faramarzi MA, Sepehrizadeh Z, Hassan ZM et al (2015) Th1 immune response induction by biogenic selenium nanoparticles in mice with breast cancer: preliminary vaccine model. Iran J Biotechnol 13(2):1\u20139. https:\/\/doi.org\/10.15171\/ijb.1056","journal-title":"Iran J Biotechnol"},{"issue":"17","key":"5026_CR144","doi-asserted-by":"publisher","first-page":"e2108167","DOI":"10.1002\/adma.202108167","volume":"34","author":"Z Wei","year":"2022","unstructured":"Wei Z, Yi Y, Luo Z, Gong X, Jiang Y, Hou D et al (2022) Selenopeptide nanomedicine activates natural killer cell for enhanced tumor chemo-immunotherapy. Adv Mater 34(17):e2108167. https:\/\/doi.org\/10.1002\/adma.202108167","journal-title":"Adv Mater"},{"issue":"12","key":"5026_CR145","doi-asserted-by":"publisher","first-page":"e1907568","DOI":"10.1002\/adma.201907568","volume":"32","author":"S Gao","year":"2020","unstructured":"Gao S, Li T, Guo Y, Sun C, Xianyu B, Xu H (2020) Selenium-containing nanoparticles combine the NK cells mediated immunotherapy with radiotherapy and chemotherapy. Adv Mater 32(12):e1907568. https:\/\/doi.org\/10.1002\/adma.201907568","journal-title":"Adv Mater"},{"key":"5026_CR146","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.nut.2018.05.022","volume":"57","author":"M Molanouri Shamsi","year":"2019","unstructured":"Molanouri Shamsi M, Chekachak S, Soudi S, Gharakhanlou R, Quinn LS, Ranjbar K et al (2019) Effects of exercise training and supplementation with selenium nanoparticle on T-helper 1 and 2 and cytokine levels in tumor tissue of mice bearing the 4 T1 mammary carcinoma. Nutrition 57:141\u2013147. https:\/\/doi.org\/10.1016\/j.nut.2018.05.022","journal-title":"Nutrition"},{"key":"5026_CR147","doi-asserted-by":"publisher","first-page":"119397","DOI":"10.1016\/j.biomaterials.2019.119397","volume":"222","author":"Y Hu","year":"2019","unstructured":"Hu Y, Liu T, Li J, Mai F, Li J, Chen Y et al (2019) Selenium nanoparticles as new strategy to potentiate \u03b3\u03b4 T cell anti-tumor cytotoxicity through upregulation of tubulin-\u03b1 acetylation. Biomaterials 222:119397. https:\/\/doi.org\/10.1016\/j.biomaterials.2019.119397","journal-title":"Biomaterials"},{"issue":"1","key":"5026_CR148","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s12011-012-9402-0","volume":"149","author":"MH Yazdi","year":"2012","unstructured":"Yazdi MH, Mahdavi M, Varastehmoradi B, Faramarzi MA, Shahverdi AR (2012) The immunostimulatory effect of biogenic selenium nanoparticles on the 4T1 breast cancer model: an in vivo study. Biol Trace Elem Res 149(1):22\u201328. https:\/\/doi.org\/10.1007\/s12011-012-9402-0","journal-title":"Biol Trace Elem Res"},{"issue":"1","key":"5026_CR149","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.arcmed.2015.01.002","volume":"46","author":"E Faghfuri","year":"2015","unstructured":"Faghfuri E, Yazdi MH, Mahdavi M, Sepehrizadeh Z, Faramarzi MA, Mavandadnejad F, Shahverdi AR (2015) Dose-response relationship study of selenium nanoparticles as an immunostimulatory agent in cancer-bearing mice. Arch Med Res 46(1):31\u201337. https:\/\/doi.org\/10.1016\/j.arcmed.2015.01.002","journal-title":"Arch Med Res"},{"issue":"4","key":"5026_CR150","doi-asserted-by":"publisher","first-page":"164","DOI":"10.3390\/ph12040164","volume":"12","author":"F Maiyo","year":"2019","unstructured":"Maiyo F, Singh M (2019) Folate-Targeted mRNA delivery using Chitosan-Functionalized selenium nanoparticles: potential in cancer immunotherapy. Pharmaceuticals (Basel) 12(4):164. https:\/\/doi.org\/10.3390\/ph12040164","journal-title":"Pharmaceuticals (Basel)"},{"issue":"8","key":"5026_CR151","doi-asserted-by":"publisher","first-page":"6578","DOI":"10.1021\/nn202452c","volume":"6","author":"W Liu","year":"2012","unstructured":"Liu W, Li X, Wong YS, Zheng W, Zhang Y, Cao W, Chen T (2012) Selenium nanoparticles as a carrier of 5-fluorouracil to achieve anticancer synergism. ACS Nano 6(8):6578\u20136591. https:\/\/doi.org\/10.1021\/nn202452c","journal-title":"ACS Nano"},{"issue":"6","key":"5026_CR152","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.carres.2011.01.027","volume":"346","author":"P Li","year":"2011","unstructured":"Li P, Wang Y, Zeng F, Chen L, Peng Z, Kong LX (2011) Synthesis and characterization of folate conjugated Chitosan and cellular uptake of its nanoparticles in HT-29 cells. Carbohydr Res 346(6):801\u2013806. https:\/\/doi.org\/10.1016\/j.carres.2011.01.027","journal-title":"Carbohydr Res"},{"key":"5026_CR153","doi-asserted-by":"publisher","first-page":"151962","DOI":"10.1016\/j.bbrc.2025.151962","volume":"769","author":"EG Varlamova","year":"2025","unstructured":"Varlamova EG, Gudkov SV, Blinova EV, Blinov DS, Turovsky EA (2025) Anticancer signal transduction pathways of selenium nanoparticles in mouse colorectal cancer model. Biochem Biophys Res Commun 769:151962. https:\/\/doi.org\/10.1016\/j.bbrc.2025.151962","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"5026_CR154","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.3390\/ijms24032411","volume":"24","author":"EG Varlamova","year":"2023","unstructured":"Varlamova EG, Khabatova VV, Gudkov SV, Turovsky EA (2023) Ca2+-Dependent effects of the Selenium-Sorafenib nanocomplex on glioblastoma cells and astrocytes of the cerebral cortex: anticancer agent and cytoprotector. Int J Mol Sci 24(3):2411. https:\/\/doi.org\/10.3390\/ijms24032411","journal-title":"Int J Mol Sci"},{"key":"5026_CR155","doi-asserted-by":"publisher","first-page":"110261","DOI":"10.1016\/j.abb.2024.110261","volume":"764","author":"EG Varlamova","year":"2025","unstructured":"Varlamova EG, Gudkov SV, Turovsky EA (2025) Differential effect of cerium nanoparticles on the viability, redox-status and Ca2+-signaling system of cancer cells of various origins. Arch Biochem Biophys 764:110261. https:\/\/doi.org\/10.1016\/j.abb.2024.110261","journal-title":"Arch Biochem Biophys"},{"issue":"2","key":"5026_CR156","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s12032-024-02598-w","volume":"42","author":"E Faderin","year":"2025","unstructured":"Faderin E, Iorkula TH, Aworinde OR, Awoyemi RF, Awoyemi CT, Acheampong E, Chukwu JU, Agyemang P, Onaiwu GE, Ifijen IH (2025) Platinum nanoparticles in cancer therapy: chemotherapeutic enhancement and ROS generation. Med Oncol 42(2):42. https:\/\/doi.org\/10.1007\/s12032-024-02598-w","journal-title":"Med Oncol"},{"issue":"4","key":"5026_CR157","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s12032-025-02633-4","volume":"42","author":"MJ Saadh","year":"2025","unstructured":"Saadh MJ, Khidr WA, Alfarttoosi KH, Bishoyi AK, Ganesan S, Shankhyan A, Gayathri S, Rizaev J, Taher WM, Alwan M, Jawad MJ, Al-Nuaimi AMA (2025) Metal nanoparticles as a promising therapeutic approach for prostate cancer diagnosis and therapy: a comprehensive review. Med Oncol 42(4):83. https:\/\/doi.org\/10.1007\/s12032-025-02633-4","journal-title":"Med Oncol"},{"key":"5026_CR158","doi-asserted-by":"publisher","unstructured":"Al-Duais MA, El Rabey HA, Mohammed GM, Al-Awthan YS, Althiyabi AS, Attia ES, Rezk SM, Tayel AA (2025) The anticancer activity of fucoidan coated selenium nanoparticles and curcumin nanoparticles against colorectal cancer lines. Sci Rep 15(1):287. Erratum in: Sci Rep. 2025;15(1):8759. https:\/\/doi.org\/10.1038\/s41598-024-82687-y. Erratum in: Sci Rep. 2025;15(1):8759. doi: 10.1038\/s41598-025-93432-4","DOI":"10.1038\/s41598-024-82687-y"},{"issue":"Pt 1","key":"5026_CR159","doi-asserted-by":"publisher","first-page":"140924","DOI":"10.1016\/j.ijbiomac.2025.140924","volume":"305","author":"K Chen","year":"2025","unstructured":"Chen K, Jiang Z, Yu J, Fu R, Yin H (2025) Interaction of zinc oxide nanoparticles and nanorods with Immunoglobulin G and underlying effects on MCF-7 breast cancer cells. Int J Biol Macromol 305(Pt 1):140924. https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.140924","journal-title":"Int J Biol Macromol"},{"issue":"3","key":"5026_CR160","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s12032-025-02609-4","volume":"42","author":"DK Sharma","year":"2025","unstructured":"Sharma DK (2025) Recent advancements in nanoparticles for cancer treatment. Med Oncol 42(3):72. https:\/\/doi.org\/10.1007\/s12032-025-02609-4","journal-title":"Med Oncol"},{"issue":"3","key":"5026_CR161","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1007\/s12010-024-05091-2","volume":"197","author":"MW Helal","year":"2025","unstructured":"Helal MW, Faried MM, Salah SM, Ashraf M, Nasser N, Shawky Y, Hamdy S, Amir AE, Nabil W, El-Husseini DM (2025) Comparative analysis of Aptamer-Conjugated chemical and green synthesized gold nanoparticles for targeted therapy in MCF-7 cancer cells. Appl Biochem Biotechnol 197(3):1678\u20131695. https:\/\/doi.org\/10.1007\/s12010-024-05091-2","journal-title":"Appl Biochem Biotechnol"},{"issue":"9","key":"5026_CR162","doi-asserted-by":"publisher","first-page":"13197","DOI":"10.1021\/acsami.4c16840","volume":"17","author":"VMO Cardoso","year":"2025","unstructured":"Cardoso VMO, Bistaffa MJ, Sterman RG, Lima LLP, Toldo GS, Cancino-Bernardi J, Zucolotto V (2025) Nanomedicine innovations for lung cancer diagnosis and therapy. ACS Appl Mater Interfaces 17(9):13197\u201313220. https:\/\/doi.org\/10.1021\/acsami.4c16840","journal-title":"ACS Appl Mater Interfaces"},{"issue":"6","key":"5026_CR163","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s12032-025-02756-8","volume":"42","author":"DP \u00c7etin","year":"2025","unstructured":"\u00c7etin DP, Se\u00e7me M, \u0130lhan H, Sa\u011flam N (2025) Alginate and chitosan-coated ferulic acid-loaded selenium nanoparticles: synthesis, characterization, and anticancer activity against MDA-MB-231 breast cancer cells. Med Oncol 42(6):198. https:\/\/doi.org\/10.1007\/s12032-025-02756-8","journal-title":"Med Oncol"},{"key":"5026_CR164","doi-asserted-by":"publisher","first-page":"68803","DOI":"10.18632\/oncotarget.11931","volume":"7","author":"A Amaro","year":"2016","unstructured":"Amaro A, Angelini G, Mirisola V, Esposito A, Reverberi D, Matis S et al (2016) A highly invasive subpopulation of MDA-MB-231 breast cancer cells shows accelerated growth, differential chemoresistance, features of apocrine tumors and reduced tumorigenicity in vivo. Oncotarget 7:68803\u201368820","journal-title":"Oncotarget"},{"key":"5026_CR165","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/leu.2010.6","volume":"24","author":"L-J Mah","year":"2010","unstructured":"Mah L-J, El-Osta A, Karagiannis TC (2010) \u03b3H2AX: a sensitive molecular marker of DNA damage and repair. Leukemia 24:679\u2013686","journal-title":"Leukemia"},{"issue":"4","key":"5026_CR166","first-page":"201","volume":"13","author":"E Faghfuri","year":"2021","unstructured":"Faghfuri E, Ajideh R, Shahverdi F, Hosseini M, Mavandadnejad F, Yazdi MH, Shahverdi AR (2021) Oct-Dec) Fabrication of calcium sulfate coated selenium nanoparticles and corresponding In-Vitro cytotoxicity effects against 4T1 breast cancer cell line. Avicenna J Med Biotechnol 13(4):201\u2013206","journal-title":"Avicenna J Med Biotechnol"},{"issue":"1","key":"5026_CR167","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.arcmed.2018.04.007","volume":"49","author":"AR Shahverdi","year":"2018","unstructured":"Shahverdi AR, Shahverdi F, Faghfuri E, Reza Khoshayand M, Mavandadnejad F, Yazdi MH, Amini M (2018) Characterization of folic acid Surface-Coated selenium nanoparticles and corresponding in vitro and in vivo effects against breast cancer. Arch Med Res 49(1):10\u201317. https:\/\/doi.org\/10.1016\/j.arcmed.2018.04.007","journal-title":"Arch Med Res"},{"issue":"4","key":"5026_CR168","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1093\/toxres\/tfaa053","volume":"9","author":"L Zhang","year":"2020","unstructured":"Zhang L, Wu X, Feng Y, Zheng L, Jian J (2020) Selenium donors inhibits osteoclastogenesis through inhibiting IL-6 and plays a pivotal role in bone metastasis from breast cancer. Toxicol Res (Camb) 9(4):544\u2013551. https:\/\/doi.org\/10.1093\/toxres\/tfaa053","journal-title":"Toxicol Res (Camb)"},{"key":"5026_CR169","doi-asserted-by":"publisher","unstructured":"Cai WL, Huang WD, Li B, Chen TR, Li ZX, Zhao CL, Li HY, Wu YM, Yan WJ, Xiao JR (2018) microRNA-124 inhibits bone metastasis of breast cancer by repressing Interleukin-11. Mol Cancer 17(1):9. Erratum in: Mol Cancer. 2020;19(1):111. https:\/\/doi.org\/10.1186\/s12943-017-0746-0. Erratum in: Mol Cancer. 2020;19(1):111. doi: 10.1186\/s12943-020-01226-1","DOI":"10.1186\/s12943-017-0746-0"},{"key":"5026_CR170","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jep.2018.12.023","volume":"232","author":"C Wu","year":"2019","unstructured":"Wu C, Chen M, Sun Z, Ye Y, Han X, Qin Y, Liu S (2019) Wenshen Zhuanggu formula mitigates breast cancer bone metastasis through the signaling crosstalk among the Jagged1\/Notch, TGF-\u03b2 and IL-6 signaling pathways. J Ethnopharmacol 232:145\u2013154. https:\/\/doi.org\/10.1016\/j.jep.2018.12.023","journal-title":"J Ethnopharmacol"},{"key":"5026_CR171","doi-asserted-by":"publisher","first-page":"101792","DOI":"10.1016\/j.toxrep.2024.101792","volume":"13","author":"BA Ali","year":"2024","unstructured":"Ali BA, Allam RM, Hasanin MS, Hassabo AA (2024) Biosynthesis of selenium nanoparticles as a potential therapeutic agent in breast cancer: G2\/M arrest and apoptosis induction. Toxicol Rep 13:101792. https:\/\/doi.org\/10.1016\/j.toxrep.2024.101792","journal-title":"Toxicol Rep"},{"issue":"1","key":"5026_CR172","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40643-018-0217-5","volume":"5","author":"Kora Aruna Jyothi","year":"2018","unstructured":"Kora Aruna Jyothi (2018) Bacillus Cereus, Selenite-reducing bacterium from contaminated lake of an industrial area: a renewable nanofactory for the synthesis of selenium nanoparticles. Bioresour Bioprocess 5(1):1\u201312. https:\/\/doi.org\/10.1186\/s40643-018-0217-5","journal-title":"Bioresour Bioprocess"},{"issue":"7","key":"5026_CR173","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/j.nano.2011.12.003","volume":"8","author":"KK Vekariya","year":"2012","unstructured":"Vekariya KK, Kaur J, Tikoo K (2012) ER\u03b1 signaling imparts chemotherapeutic selectivity to selenium nanoparticles in breast cancer. Nanomedicine 8(7):1125\u20131132. https:\/\/doi.org\/10.1016\/j.nano.2011.12.003","journal-title":"Nanomedicine"},{"issue":"15","key":"5026_CR174","doi-asserted-by":"publisher","first-page":"7798","DOI":"10.3390\/ijms22157798","volume":"22","author":"EG Varlamova","year":"2021","unstructured":"Varlamova EG, Goltyaev MV, Mal\u2019tseva VN, Turovsky EA, Sarimov RM, Simakin AV, Gudkov SV (2021) Mechanisms of the cytotoxic effect of selenium nanoparticles in different human cancer cell lines. Int J Mol Sci 22(15):7798. https:\/\/doi.org\/10.3390\/ijms22157798","journal-title":"Int J Mol Sci"},{"issue":"10","key":"5026_CR175","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.3390\/cancers14102560","volume":"14","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, Wang H, Zhou J, Shao Q (2022) Glutathione peroxidase GPX1 and its dichotomous roles in cancer. Cancers (Basel) 14(10):2560. https:\/\/doi.org\/10.3390\/cancers14102560","journal-title":"Cancers (Basel)"},{"key":"5026_CR176","doi-asserted-by":"publisher","first-page":"114365","DOI":"10.1016\/j.bcp.2020.114365","volume":"184","author":"S Nirgude","year":"2021","unstructured":"Nirgude S, Choudhary B (2021) Insights into the role of GPX3, a highly efficient plasma antioxidant, in cancer. Biochem Pharmacol 184:114365. https:\/\/doi.org\/10.1016\/j.bcp.2020.114365","journal-title":"Biochem Pharmacol"},{"issue":"24","key":"5026_CR177","doi-asserted-by":"publisher","first-page":"12165","DOI":"10.18632\/aging.102555","volume":"11","author":"Y Cheng","year":"2019","unstructured":"Cheng Y, Xu T, Li S, Ruan H (2019) GPX1, a biomarker for the diagnosis and prognosis of kidney cancer, promotes the progression of kidney cancer. Aging 11(24):12165\u201312176. https:\/\/doi.org\/10.18632\/aging.102555","journal-title":"Aging"},{"issue":"4","key":"5026_CR178","doi-asserted-by":"publisher","first-page":"124","DOI":"10.21037\/atm.2020.02.36","volume":"8","author":"R Wei","year":"2020","unstructured":"Wei R, Qiu H, Xu J, Mo J, Liu Y, Gui Y, Huang G, Zhang S, Yao H, Huang X, Gan Z (2020) Expression and prognostic potential of GPX1 in human cancers based on data mining. Ann Transl Med 8(4):124. https:\/\/doi.org\/10.21037\/atm.2020.02.36","journal-title":"Ann Transl Med"},{"key":"5026_CR179","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1134\/S1607672911060056","volume":"441","author":"EG Varlamova","year":"2011","unstructured":"Varlamova EG, Novoselov SV, Novoselov VI, Fesenko EE (2011) New mammalian selenium-containing protein V: the search for protein partners. Dokl Biochem Biophys 441:255\u2013257 https:\/\/doi.org\/10.1134\/S1607672911060056","journal-title":"Dokl Biochem Biophys"},{"issue":"5","key":"5026_CR180","first-page":"819","volume":"46","author":"EG Varlamova","year":"2012","unstructured":"Varlamova EG, Novos\u00eblov VI (2012) [Co-localization of selenium-containing protein V (seIV) and its partners in mammalian cells]. Mol Biol (Mosk) 46(5):819\u2013821","journal-title":"Mol Biol (Mosk) Sep-Oct"},{"issue":"22","key":"5026_CR181","doi-asserted-by":"publisher","first-page":"15847","DOI":"10.18632\/oncotarget.24627","volume":"9","author":"T Naiki","year":"2018","unstructured":"Naiki T, Naiki-Ito A, Iida K, Etani T, Kato H, Suzuki S, Yamashita Y, Kawai N, Yasui T, Takahashi S (2018) GPX2 promotes development of bladder cancer with squamous cell differentiation through the control of apoptosis. Oncotarget 9(22):15847\u201315859. https:\/\/doi.org\/10.18632\/oncotarget.24627","journal-title":"Oncotarget"},{"issue":"6","key":"5026_CR182","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1096\/fba.2022-00045","volume":"5","author":"F Peng","year":"2023","unstructured":"Peng F, Xu Q, Jing X, Chi X, Zhang Z, Meng X, Liu X, Yan J, Liu X, Shao S (2023) GPX2 promotes EMT and metastasis in non-small cell lung cancer by activating PI3K\/AKT\/mTOR\/Snail signaling axis. FASEB Bioadv 5(6):233\u2013250. https:\/\/doi.org\/10.1096\/fba.2022-00045","journal-title":"FASEB Bioadv"},{"key":"5026_CR183","doi-asserted-by":"publisher","first-page":"116844","DOI":"10.1016\/j.taap.2024.116844","volume":"484","author":"I Bramatti","year":"2024","unstructured":"Bramatti I, Aschner M, Branco V, Carvalho C (2024) Exposure of human glioblastoma cells to thimerosal inhibits the thioredoxin system and decreases tumor growth-related factors. Toxicol Appl Pharmacol 484:116844. https:\/\/doi.org\/10.1016\/j.taap.2024.116844","journal-title":"Toxicol Appl Pharmacol"},{"issue":"2","key":"5026_CR184","first-page":"276","volume":"46","author":"EG Varlamova","year":"2012","unstructured":"Varlamova EG, Novoselov VI (2012) [The search of partners of a new mammalian selenium-containing protein V (SelV) and expression it\u2019s mRNA during ontogenesis and spermatogenesis]. Mol Biol (Mosk) 46(2):276\u2013284","journal-title":"Mol Biol (Mosk) Mar-Apr"},{"key":"5026_CR185","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1134\/S1607672914040048","volume":"457","author":"MV Goltyaev","year":"2014","unstructured":"Goltyaev MV, Varlamova EG, Novoselov VI, Fesenko EE (2014) Determination of mgpx6 and Mselv gene mRNA expression during mouse postnatal development. Dokl Biochem Biophys 457:132\u2013133. https:\/\/doi.org\/10.1134\/S1607672914040048","journal-title":"Dokl Biochem Biophys"},{"key":"5026_CR186","doi-asserted-by":"publisher","unstructured":"Varlamova EG, Novoselov SV, Novoselov VI (2015) [cDNA cloning, expression and determination of substrate specificity of mice selenocysteine-containing protein SelV (Selenoprotein V)]. Mol biol (Mosk). 49(5):785\u2013789 Russian. doi https:\/\/doi.org\/10.7868\/S0026898415050183","DOI":"10.7868\/S0026898415050183"},{"issue":"9","key":"5026_CR187","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.3390\/antiox13091078","volume":"13","author":"R Seitz","year":"2024","unstructured":"Seitz R, T\u00fcmen D, Kunst C, Heumann P, Schmid S, Kandulski A, M\u00fcller M, G\u00fclow K (2024) Exploring the thioredoxin system as a therapeutic target in cancer: mechanisms and implications. Antioxid (Basel) 13(9):1078. https:\/\/doi.org\/10.3390\/antiox13091078","journal-title":"Antioxid (Basel)"},{"issue":"11","key":"5026_CR188","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.3390\/antiox9111151","volume":"9","author":"M Jaganjac","year":"2020","unstructured":"Jaganjac M, Milkovic L, Sunjic SB, Zarkovic N (2020) The NRF2, Thioredoxin, and glutathione system in tumorigenesis and anticancer therapies. Antioxid (Basel) 9(11):1151. https:\/\/doi.org\/10.3390\/antiox9111151","journal-title":"Antioxid (Basel)"},{"key":"5026_CR189","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1146\/annurev-pharmtox-052220-102509","volume":"62","author":"R Gencheva","year":"2022","unstructured":"Gencheva R, Arn\u00e9r ESJ (2022) Thioredoxin reductase Inhibition for cancer therapy. Annu Rev Pharmacol Toxicol 62:177\u2013196. https:\/\/doi.org\/10.1146\/annurev-pharmtox-052220-102509","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"1","key":"5026_CR190","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1134\/S1607672916030121","volume":"468","author":"EG Varlamova","year":"2016","unstructured":"Varlamova EG, Goltyaev MV, Fesenko EE (2016) Expression of human Selenoprotein genes selh, selk, selm, sels, selv, and gpx-6 in various tumor cell lines. Dokl Biochem Biophys 468(1):203\u2013205. https:\/\/doi.org\/10.1134\/S1607672916030121","journal-title":"Dokl Biochem Biophys"},{"issue":"1","key":"5026_CR191","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1134\/S160767291705012X","volume":"476","author":"EG Varlamova","year":"2017","unstructured":"Varlamova EG, Goltyaev MV, Novoselov VI, Fesenko EE (2017) Cloning, intracellular localization, and expression of the mammalian selenocysteine-containing protein SELENOI (SelI) in tumor cell lines. Dokl Biochem Biophys 476(1):320\u2013322. https:\/\/doi.org\/10.1134\/S160767291705012X","journal-title":"Dokl Biochem Biophys"},{"key":"5026_CR192","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jtemb.2018.04.005","volume":"48","author":"EG Varlamova","year":"2018","unstructured":"Varlamova EG (2018) Participation of selenoproteins localized in the ER in the processes occurring in this organelle and in the regulation of carcinogenesis-associated processes. J Trace Elem Med Biol 48:172\u2013180. https:\/\/doi.org\/10.1016\/j.jtemb.2018.04.005","journal-title":"J Trace Elem Med Biol"},{"key":"5026_CR193","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.biochi.2020.03.012","volume":"171\u2013172","author":"EG Varlamova","year":"2020","unstructured":"Varlamova EG (2020) Protein-protein interactions of ER-resident selenoproteins with their physiological partners. Biochimie 171\u2013172:197\u2013204 https:\/\/doi.org\/10.1016\/j.biochi.2020.03.012","journal-title":"Biochimie"},{"issue":"6","key":"5026_CR194","doi-asserted-by":"publisher","first-page":"811","DOI":"10.3390\/biology11060811","volume":"11","author":"EG Varlamova","year":"2022","unstructured":"Varlamova EG, Goltyaev MV, Turovsky EA (2022) The role of selenoproteins SELENOM and SELENOT in the regulation of Apoptosis, ER Stress, and calcium homeostasis in the A-172 human glioblastoma cell line. Biology (Basel) 11(6):811. https:\/\/doi.org\/10.3390\/biology11060811","journal-title":"Biology (Basel)"},{"issue":"7","key":"5026_CR195","doi-asserted-by":"publisher","first-page":"6469","DOI":"10.3390\/ijms24076469","volume":"24","author":"VV Rogachev","year":"2023","unstructured":"Rogachev VV, Goltyaev MV, Varlamova EG, Turovsky EA (2023) Molecular mechanisms of the cytotoxic effect of Recombinant Selenoprotein SELENOM on human glioblastoma cells. Int J Mol Sci 24(7):6469. https:\/\/doi.org\/10.3390\/ijms24076469","journal-title":"Int J Mol Sci"},{"key":"5026_CR196","doi-asserted-by":"publisher","first-page":"110344","DOI":"10.1016\/j.abb.2025.110344","volume":"766","author":"EG Varlamova","year":"2025","unstructured":"Varlamova EG (2025) Roles of selenium-containing glutathione peroxidases and thioredoxin reductases in the regulation of processes associated with glioblastoma progression. Arch Biochem Biophys 766:110344. https:\/\/doi.org\/10.1016\/j.abb.2025.110344","journal-title":"Arch Biochem Biophys"},{"key":"5026_CR197","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1134\/S0006350919040213","volume":"64","author":"EG Varlamova","year":"2019","unstructured":"Varlamova EG, Maltseva VN (2019) Micronutrient selenium: uniqueness and vital functions. Biophysics 64:510\u2013521. https:\/\/doi.org\/10.1134\/S0006350919040213","journal-title":"Biophysics"},{"issue":"1","key":"5026_CR198","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1186\/s12967-020-02420-x","volume":"18","author":"ML Zhang","year":"2020","unstructured":"Zhang ML, Wu HT, Chen WJ, Xu Y, Ye QQ, Shen JX, Liu J (2020) Involvement of glutathione peroxidases in the occurrence and development of breast cancers. J Transl Med 18(1):247. https:\/\/doi.org\/10.1186\/s12967-020-02420-x","journal-title":"J Transl Med"},{"issue":"8","key":"5026_CR199","doi-asserted-by":"publisher","first-page":"e2107266119","DOI":"10.1073\/pnas.2107266119","volume":"119","author":"Z Ren","year":"2022","unstructured":"Ren Z, Liang H, Galbo PM Jr, Dharmaratne M, Kulkarni AS, Fard AT, Aoun ML, Martinez-Lopez N, Suyama K, Benard O, Zheng W, Liu Y, Albanese J, Zheng D, Mar JC, Singh R, Prystowsky MB, Norton L, Hazan RB (2022) Redox signaling by glutathione peroxidase 2 links vascular modulation to metabolic plasticity of breast cancer. Proc Natl Acad Sci U S A 119(8):e2107266119. https:\/\/doi.org\/10.1073\/pnas.2107266119","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5026_CR200","doi-asserted-by":"publisher","first-page":"101391","DOI":"10.1016\/j.redox.2019.101391","volume":"29","author":"E Lee","year":"2020","unstructured":"Lee E, Choi A, Jun Y, Kim N, Yook JI, Kim SY, Lee S, Kang SW (2020) Glutathione peroxidase-1 regulates adhesion and metastasis of triple-negative breast cancer cells via FAK signaling. Redox Biol 29:101391. https:\/\/doi.org\/10.1016\/j.redox.2019.101391","journal-title":"Redox Biol"},{"issue":"5","key":"5026_CR201","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1016\/j.ijrobp.2010.11.002","volume":"79","author":"CM Woolston","year":"2011","unstructured":"Woolston CM, Al-Attar A, Storr SJ, Ellis IO, Morgan DA, Martin SG (2011) Redox protein expression predicts radiotherapeutic response in early-stage invasive breast cancer patients. Int J Radiat Oncol Biol Phys 79(5):1532\u20131540. https:\/\/doi.org\/10.1016\/j.ijrobp.2010.11.002","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"5026_CR202","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1055\/s-0040-1722170","volume":"7","author":"P Saelee","year":"2020","unstructured":"Saelee P, Pongtheerat T, Sophonnithiprasert T (2020) Reduced expression of GPX3 in breast cancer patients in correlation with clinical significance. Glob Med Genet 7(3):87\u201391. https:\/\/doi.org\/10.1055\/s-0040-1722170","journal-title":"Glob Med Genet"},{"issue":"6","key":"5026_CR203","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1080\/10715760701286167","volume":"41","author":"P Cejas","year":"2007","unstructured":"Cejas P, Garc\u00eda-Cabezas MA, Casado E, Belda-Iniesta C, De Castro J, Fresno JA, Sereno M, Barriuso J, Espinosa E, Zamora P, Feliu J, Redondo A, Hardisson DA, Renart J, Gonz\u00e1lez-Bar\u00f3n M (2007) Phospholipid hydroperoxide glutathione peroxidase (PHGPx) expression is downregulated in poorly differentiated breast invasive ductal carcinoma. Free Radic Res 41(6):681\u2013687. https:\/\/doi.org\/10.1080\/10715760701286167","journal-title":"Free Radic Res"},{"issue":"1","key":"5026_CR204","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1186\/s12967-023-04502-y","volume":"21","author":"K Demircan","year":"2023","unstructured":"Demircan K, Bengtsson Y, Chillon TS, Vallon-Christersson J, Sun Q, Larsson C, Malmberg M, Saal LH, Ryd\u00e9n L, Borg \u00c5, Manjer J, Schomburg L (2023) Matched analysis of Circulating selenium with the breast cancer selenotranscriptome: a multicentre prospective study. J Transl Med 21(1):658. https:\/\/doi.org\/10.1186\/s12967-023-04502-y","journal-title":"J Transl Med"},{"issue":"9","key":"5026_CR205","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1038\/s41388-021-02158-w","volume":"41","author":"A Zigrossi","year":"2022","unstructured":"Zigrossi A, Hong LK, Ekyalongo RC, Cruz-Alvarez C, Gornick E, Diamond AM, Kastrati I (2022) SELENOF is a new tumor suppressor in breast cancer. Oncogene 41(9):1263\u20131268. https:\/\/doi.org\/10.1038\/s41388-021-02158-w","journal-title":"Oncogene"},{"issue":"3","key":"5026_CR206","doi-asserted-by":"publisher","first-page":"486","DOI":"10.3390\/biom13030486","volume":"13","author":"B Flowers","year":"2023","unstructured":"Flowers B, Bochnacka O, Poles A, Diamond AM, Kastrati I (2023) Distinct roles of SELENOF in different human cancers. Biomolecules 13(3):486. https:\/\/doi.org\/10.3390\/biom13030486","journal-title":"Biomolecules"},{"issue":"14","key":"5026_CR207","doi-asserted-by":"publisher","first-page":"3671","DOI":"10.3390\/cancers15143671","volume":"15","author":"RC Ekyalongo","year":"2023","unstructured":"Ekyalongo RC, Flowers B, Sharma T, Zigrossi A, Zhang A, Quintanilla-Arteaga A, Singh K, Kastrati I (2023) SELENOF controls proliferation and cell death in Breast-Derived immortalized and cancer cells. Cancers (Basel) 15(14):3671. https:\/\/doi.org\/10.3390\/cancers15143671","journal-title":"Cancers (Basel)"},{"key":"5026_CR208","doi-asserted-by":"publisher","first-page":"102198","DOI":"10.1016\/j.bbrep.2025.102198","volume":"43","author":"G Tang","year":"2025","unstructured":"Tang G, Zhang Z, Pang B, Li R, Liu Y, Cai H, Wang W, Chen C, Ou Y, Yang Q (2025) Integrated multi-omics analysis identifies SELENOP and PKMYT1 as immune-metabolic hub genes in breast cancer. Biochem Biophys Rep 43:102198. https:\/\/doi.org\/10.1016\/j.bbrep.2025.102198","journal-title":"Biochem Biophys Rep"},{"key":"5026_CR209","doi-asserted-by":"publisher","first-page":"618172","DOI":"10.3389\/fphar.2021.618172","volume":"12","author":"S Bevinakoppamath","year":"2021","unstructured":"Bevinakoppamath S, Saleh Ahmed AM, Ramachandra SC, Vishwanath P, Prashant A (2021) Chemopreventive and anticancer property of selenoproteins in obese breast cancer. Front Pharmacol 12:618172. https:\/\/doi.org\/10.3389\/fphar.2021.618172","journal-title":"Front Pharmacol"},{"key":"5026_CR210","doi-asserted-by":"publisher","first-page":"110241","DOI":"10.1016\/j.abb.2024.110241","volume":"764","author":"EA Turovsky","year":"2025","unstructured":"Turovsky EA, Plotnikov EY, Simakin AV, Gudkov SV, Varlamova EG (2025) New magnetic iron nanoparticle doped with selenium nanoparticles and the mechanisms of their cytoprotective effect on cortical cells under ischemia-like conditions. Arch Biochem Biophys 764:110241. https:\/\/doi.org\/10.1016\/j.abb.2024.110241","journal-title":"Arch Biochem Biophys"},{"issue":"8","key":"5026_CR211","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.3390\/biomedicines12081756","volume":"12","author":"EA Turovsky","year":"2024","unstructured":"Turovsky EA, Plotnikov EY, Varlamova EG (2024) Regulatory role and cytoprotective effects of exogenous Recombinant SELENOM under Ischemia-like conditions and glutamate excitotoxicity in cortical cells in vitro. Biomedicines 12(8):1756. https:\/\/doi.org\/10.3390\/biomedicines12081756","journal-title":"Biomedicines"},{"key":"5026_CR212","doi-asserted-by":"publisher","unstructured":"Varlamova EG, Gudkov SV, Turovsky EA (2025) Opposite effects of small and large diameter selenium nanoparticles on the Redox-Status and survival of cortical cells in toxic models in vitro. Biol Trace Elem Res 29 https:\/\/doi.org\/10.1007\/s12011-025-04682-2","DOI":"10.1007\/s12011-025-04682-2"},{"issue":"9","key":"5026_CR213","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.3390\/biom15091336","volume":"15","author":"EA Turovsky","year":"2025","unstructured":"Turovsky EA, Gudkov SV, Varlamova EG (2025) Therapeutic effect of selenium Nanoparticles, Sorafenib, and selenium-Sorafenib nanocomplex in the lungs and kidneys of mice with TAA-Induced HCC. Biomolecules 15(9):1336. https:\/\/doi.org\/10.3390\/biom15091336","journal-title":"Biomolecules"},{"issue":"1","key":"5026_CR214","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1097\/MS9.0000000000004480","volume":"88","author":"EI Obeagu","year":"2025","unstructured":"Obeagu EI (2025) Therapeutic potential of selenium in breast cancer: targeting apoptosis and proliferation pathways. Ann Med Surg (Lond) 88(1):597\u2013609. https:\/\/doi.org\/10.1097\/MS9.0000000000004480","journal-title":"Ann Med Surg (Lond)"},{"issue":"6","key":"5026_CR215","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.21873\/anticanres.17036","volume":"44","author":"K Mokbel","year":"2024","unstructured":"Mokbel K, Mokbel K (2024) Harnessing micronutrient power: Vitamins, antioxidants and probiotics in breast cancer prevention. Anticancer Res 44(6):2287\u20132295. https:\/\/doi.org\/10.21873\/anticanres.17036","journal-title":"Anticancer Res"}],"container-title":["Biological Trace Element Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12011-026-05026-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12011-026-05026-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12011-026-05026-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T05:51:03Z","timestamp":1782798663000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12011-026-05026-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,13]]},"references-count":215,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["5026"],"URL":"https:\/\/doi.org\/10.1007\/s12011-026-05026-4","relation":{},"ISSN":["1559-0720"],"issn-type":[{"value":"1559-0720","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,13]]},"assertion":[{"value":"17 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}